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Abstract
This prospective cohort study evaluated the usual care pathway for patients referred to total knee
arthroplasty (TKA). We measured healthcare resource use, costs, and health-related quality of life
(HRQoL) over the continuum of care. We also determined the proportion of inappropriate referrals
and estimated wait times for initial surgical consultation and TKA.
We found that two in five patients referred to specialty care were deemed inappropriate surgical
candidates. Prior to referral, few conservative treatment options were tried, and many imaging tests
ordered by referring providers were unjustified. Overall, the greatest proportion of costs was borne by
the patient or private insurer, with the minority incurred by the public payer. Surgery was associated
with improved HRQoL. The results of this study can provide valuable guidance on the design and
implementation of a new electronic referral pathway (NRP) to promote appropriate and timely
referral and manage excessive wait times for TKA.
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Chapter 1

1

Introduction

Osteoarthritis (OA) is a prevalent, debilitating and costly disease that results in the
degeneration of the structure and function of synovial joints, commonly affecting the knees
and hips.1 As of 2011, nearly 13% of Canadians are living with OA.2 Total knee arthroplasty
(TKA) is a highly cost-effective procedure for patients who suffer from end-stage knee OA
and experience debilitating pain and loss of function despite conservative management.3 The
current national wait time benchmarks for total joint arthroplasty (TJA) are 3 months for
surgical consultation after referral from a general practitioner (GP), and 6 months for surgery
after the decision to operate has been made.4 Reducing wait times for TJA was identified as
one of four priority areas by Canadian First Ministers in 20045 yet, despite recent efforts to
improve access to care, the average wait time for TJA continues to exceed the clinically
acceptable benchmark. According to the 2017 Fraser Institute Report, the waits between GP
referral and surgical consultation (4.5 months) and between referral and surgery (10.4
months) are the longest among all specialties.6 The growing proportion of Canadians over the
age of 65, coupled with recent technological advances in arthroplasty and improved patient
outcomes, suggests that the demand for TKA will continue to rise across all age groups.7–9
Excessive wait times for TKA impact patient health and impose an economic burden on both
patients and the healthcare system. Previous studies suggest that most patients experience a
significant decline in health-related quality of life (HRQoL) while waiting for TKA10, and
that longer wait times are associated with lower post-operative HRQoL.11,12 Furthermore,
poorer pre-surgery health status was found to be a significant predictor of worse outcomes
and higher costs post-operatively.13–16 A 2008 study commissioned by the Canadian Medical
Association assessed the economic impact of waiting for four priority procedures and found
that wait times for TJA amounted to the highest societal costs.17 OA-related costs have also
been reported to increase with disease severity.18,19 A large proportion of these costs can be
attributed to patient and caregiver productivity losses, as an estimated 32% of patients
waiting to undergo TJA are unable to engage in their usual activities.17,20 The considerable
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societal impact of waiting for TKA underscores the importance of developing innovative
strategies to minimize wait times.
Wait times for procedures arise when the demand exceeds the supply and serve to ration
access to medical services, particularly within publicly-funded healthcare systems.21
However, wait times for TKA vary widely not only between but also within provinces.22
According to the 2014 Wait Time Alliance report, simply increasing funding is an
unsustainable strategy to manage wait times; structural changes must also be made in
primary care.23 GPs play a central role in diagnosing knee OA, managing symptoms nonoperatively, and deciding who and when to refer to an orthopedic specialist for surgical
treatment. Despite the existence of clinical guidelines for the management of knee OA in
primary care24,25, a large proportion of patients referred for TKA are inappropriate surgical
candidates. Klett et al.26 reported that 47% of patients referred to an orthopedic surgical
screening clinic were unsuitable for TKA and redirected back to their referring GP with
recommendations for conservative management. At our centre, the proportion of
inappropriate referrals was previously found to be over 40%.27,28 The high rate of
inappropriate patients referred for TKA may stem from referring physicians’ uncertainty and
misperceptions about surgical suitability. A study conducted in the 1990s found that GPs in
Ontario widely disagreed about appropriate treatments for knee OA and the indications for
TKA referral.29 Recent surveys indicate that GPs’ perceptions about surgical suitability
continue to vary.30,31 These findings highlight the need for clear and consistent indications to
support GPs in referring appropriate surgical candidates for consideration of TKA.
One approach to managing wait times is to optimize the referral process by reducing the rate
of nonsurgical referrals. To inform the development of a new electronic referral or e-referral
pathway (NRP), we previously developed and validated a model that can correctly predict
whether a patient referred to an orthopedic surgeon is scheduled for TKA in 70% of the
cases.27,28 The goal of the NRP is to expedite access to specialty care for patients who are
sufficiently symptomatic, have exhausted non-operative treatments, and are willing to
undergo surgery. To facilitate decision-making in primary care, the NRP will include
educational videos to provide patients and GPs with guidance on appropriate diagnostic
imaging tests, conservative management options, the surgical procedure, and post-operative
expectations. In light of this larger objective, the aim of this study was to measure wait times,
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costs, HRQoL, and healthcare resource use among patients with knee OA over the continuum
of usual care, prior to the implementation of the NRP.

4

Chapter 2

2

Literature Review

The two main objectives of this literature review are to: (1) explore the underlying reasons
for the current evidence-to-practice gap in primary care that contributes to excessive wait
times for TKA, and (2) identify strategies to bridge this gap and translate evidence-based
recommendations into practice and inform the design of our proposed NRP. To address the
first objective, we will summarize and evaluate the quality of current clinical practice
guidelines (CPGs) for the management of knee OA and explore factors contributing to the
high rate of inappropriate referrals for TKA, overuse of unwarranted diagnostic imaging
tests, and inefficiency of the current referral system. To meet the second objective, we will
discuss the tenets of knowledge translation (KT), electronic (e-)learning in patient and
provider education, and existing wait time management strategies (WTMS) and e-referral
systems. Lastly, we will integrate the findings and apply them to our proposed NRP.

2.1 Evidence-to-Practice Gap in Primary Care Management of OA
Practicing within the constraints of Canada’s publicly-funded healthcare system, GPs must
have the skills and expertise to effectively manage the symptoms of knee OA, while
judiciously referring select patients to TKA at the appropriate time. To facilitate evidencebased clinical decision-making in primary care, many national and international
organizations have published CPGs for the management of knee OA. However, the current
misuse of diagnostic imaging tests, inadequate provision of conservative treatments, and
inappropriate referral to specialty care indicate that their uptake has been poor. To address
these issues and improve the quality of patient care, we must first evaluate existing CPGs to
shed light on the barriers to their implementation.

2.1.1 Clinical Practice Guidelines for the Management of OA
According to the Institute of Medicine (IOM), CPGs are “systematically developed
statements to assist practitioner and patient decisions about appropriate healthcare for
specific clinical circumstances.”32 The five leading guidelines for the conservative
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management of knee OA were developed by the OA Research Society International
(OARSI)33, the European League Against Rheumatism (EULAR)34, the National Institute for
Health and Care Excellence (NICE)35 in the United Kingdom (UK), the American Academy
of Orthopedic Surgeons (AAOS)25 and the American College of Rheumatology (ACR)36 in
the United States (US).

2.1.1.1 Summary and Comparison of Guidelines
All guidelines consistently recommend that patients be offered a set core conservative
treatments before TKA is considered, including a combination of pharmacological and
nonpharmacological modalities.37 Initially, GPs should provide patients with education on
self-management, exercise (including referral to physiotherapy), weight loss, and activity
modification. Recommended pharmacotherapy includes non-steroidal anti-inflammatory
drugs (NSAIDs), acetaminophen, tramadol, and intra-articular (IA) corticosteroid injections.
Only those patients who continue to experience significant pain and functional impairment
despite conservative management should be referred to an orthopedic surgeon for
consideration of TKA.
To facilitate comparison, Table 1 outlines key quality and reporting features of the five
leading CPGs. Despite significant variation in the clinical presentation of OA in different
joints, only the OARSI and AAOS guidelines focus specifically on the knee joint. The
EULAR guideline focuses on both hip and knee OA, while the NICE and ACR guidelines
provide recommendations for the management of knee, hip and hand OA. It is worth noting
that the OARSI made the first effort to improve guideline applicability to patients with
comorbidities and multi-joint OA by providing separate recommendations for four patient
types: (1) knee OA without comorbidities, (2) multi-joint OA without comorbidities, (3) knee
OA with comorbidities, and (4) multi-joint OA with comorbidities.
In 2008, the IOM established eight standards for developing high-quality, trustworthy
CPGs.32 However, there is considerable heterogeneity among guidelines in the methods used
to select expert panelists and formulate consensus- and evidence-based recommendations.
The IOM emphasized that a balanced, multidisciplinary expert panel is crucial for developing
unbiased guidelines32, yet the five panels varied significantly in size (ranging from 11 to 21
members) and the scope of represented disciplines. Furthermore, while patient-centered care
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is considered the cornerstone of quality clinical practice, patient values and preferences are
not routinely incorporated into the guideline development process.38 Of the five CPGs, only
the NICE and EULAR panels included patient representatives and described their
contribution. However, to facilitate interpretation of treatment outcomes, all guidelines
except the ACR reported a summary measure of effect size (ES), such as the standardized
mean difference (SMD) or odds ratio (OR), with 95% confidence intervals (CIs) when
evidence from a meta-analysis was available. CPGs also provided some indication of the
strength of recommendations to reflect the quality of supporting evidence and the risks and
benefits associated with each treatment.
Table 1: Key quality and reporting features of leading guidelines for the management of OA
OARSI (2014)
International

EULAR (2013)
International

NICE (2014)
National (UK)

AAOS (2013)
National (US)

ACR (2012)
National (US)

Joint(s)

Knee

Hip and knee

Hip, hand, knee

Knee

Hip, hand, knee

Expert panel

n = 13
(5 disciplines)

n = 21
(10 disciplines;
2 patients)

n = 18
(7 disciplines;
2 patients)

n = 11
(4 disciplines)

n = 14
(7 disciplines)

Development
methods

Delphi consensus,
RAND/UCLA
Appropriateness

Delphi consensus
approach

GRADE approach

GRADE approach

GRADE approach

No. of treatment
recommendations

25 (separate for 4
patient types)

11

N/A
(bullet-point
recommendations)

15

N/A
(recommendations
outlined in tables)

No. of
recommendations
based on grade A
evidence39

20 of 25 (80%)

9 of 11 (82%)

N/A

6 of 15 (40%)

N/A

Indications of
recommendation
strength

Appropriate,
inappropriate or
uncertain; mean
risk and benefit
scores (95% CI)

Level of evidence
(I-IV); mean level
of agreement
(95% CI)

Implicit in wording

Strong, moderate,
limited, or
inconclusive

Strong, weak, or
none

None

Measures of ES
Guideline quality
(no. of AGREE II
domains met)40
No. of competing
interests40

SMD (95% CI)

SMD (95% CI)

SMD (95% CI)

SMD/OR/raw
mean difference
(95% CI)

1 of 5

3 of 5

5 of 5

1 of 5

1 of 5

2

3

25

35

84
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2.1.1.2 Quality of Guideline Development and Reporting
Given the multitude of existing CPGs, two recent systematic reviews have been conducted to
evaluate their methodological quality, levels of supporting evidence, and prevalence of
competing interests.39,40 Methodological quality was assessed using the Appraisal of
Guidelines for Research and Evaluation II (AGREE II) instrument41, which consists of six
domains:
1. Scope and purpose (overall objective and target population).
2. Stakeholder involvement (guideline development by relevant stakeholders/intended
users).
3. Rigour of development (systematic review of the evidence).
4. Clarity of presentation (language, structure, and format).
5. Applicability (potential facilitators and barriers to implementation and cost implications).
6. Editorial independence (bias and competing interests).
Feuerstein et al.40 determined whether each CPGs satisfied key quality measures in the first
five domains of the AGREE II tool, and assessed the sixth domain separately to discuss
issues of editorial independence. Only the NICE guideline proposed strategies to promote
uptake into practice (applicability domain), thereby meeting the quality measures in all five
domains. The authors reported that conflicts of interest were present in all guidelines
(ranging from two in the OARSI to 84 in the AAOS), undermining their methodological
transparency and validity. In a similar review, Nelson et al.39 evaluated the extent to which
CPGs satisfied the AGREE II tool domains (0% to 100%) and found that every guideline
scored lowest in the applicability domain. Given that the fundamental goal of CPGs is to
translate evidence into practice, the lack of emphasis on applicability and implementation
seems contradictory to their purpose.
In addition, Feuerstein et al.40 also evaluated the quality of supporting evidence using an
ABC grading system, in which multiple randomized controlled trials (RCTs) and metaanalyses provide the highest level of evidence (grade A), followed by single RCTs and nonrandomized studies (grade B), and lastly expert opinion or case studies (grade C). Given the
format of the NICE and ACR guidelines, they could not be mapped onto the ABC system
and were therefore excluded. The majority of the EULAR (9 of 11; 82%) and OARSI (20 of
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25; 80%) recommendations were supported by grade A evidence, compared to only 40% (6
of 15) in the AAOS guideline.
The comparison and quality assessment of five highly prominent CPGs demonstrate
considerable variability in guideline development methods and a high prevalence of
competing interests. However, their overall agreement on most recommendations suggests
inadequate dissemination and implementation at the primary care level.

2.1.2 Inappropriate Referral for TKA
Current studies suggest that approximately half of the patients referred for surgical
consideration are deemed inappropriate candidates for TKA26–28,42, most often due to
insufficient symptoms or OA severity, inadequate conservative management, and
unwillingness to undergo surgery.27,28 Thus, the mere availability of CPGs appears to be
insufficient for evidence-based practice.
The issue of inappropriate referral to TKA is complex and multifactorial and appears to result
from an interplay of individual-, local- and system-level factors. The literature offers a
plethora of possible factors contributing to the evidence-to-practice gap, including
suboptimal CPGs, inadequate family medicine training, ongoing disagreement about the
indications for TKA, and failure to assess patient values and preferences prior to referral. To
gain a better understanding of the needs of patients and GPs, we will discuss the following
shortcomings of current CPGs: contradicting treatment recommendations, impractical and
illogical formats, lack of applicability to clinical practice, and limited guidance on the
multidisciplinary management of knee OA.

2.1.2.1 Contradicting Treatment Recommendations
Although there is considerable overlap across the multitude of CPGs for OA management,
some recommendations are inconsistent. Discrepancies exist in recommendations for the use
of IA hyaluronic acid (HA) injections, glucosamine and chondroitin, acupuncture, manual
therapy, ultrasound, transcutaneous electrical nerve stimulation (TENS), knee bracing,
orthotics, duloxetine, topical capsaicin and lateral wedge insoles.39,43 These inconsistencies
may be partly explained by the aforementioned variation in the quality of supporting
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evidence and methodological rigour across guidelines.44,45 Furthermore, some CPGs are often
revised34,43, while others may be out of date with the latest research evidence.25,36 Although
this may instill confusion and mistrust, guidelines consistently recommend a set of core
conservative treatments, suggesting that there are other factors that contribute to suboptimal
management and inappropriate referral.

2.1.2.2 Lack of Practical Guidelines
The formats of many CPGs are cumbersome and impractical, posing a major obstacle to
uptake and adherence. For instance, the AAOS guideline provides 15 recommendations for
the treatment of knee OA in a report that exceeds 1,000 pages.25 Recommendations also lack
any logical order, given the absence of evidence to support treatment modalities in patients in
whom preceding treatments failed to control symptoms.46 For example, the most recent
OARSI guideline listed treatments in alphabetical order and adopted a rather conservative
and arguably uninformative approach by classifying nearly half of the recommendations as
“uncertain” (59% of pharmaceutical and 33% of nonpharmaceutical treatment
recommendations; 47% in total).43 On the other hand, the updated NICE guideline adopted
the most user-friendly layout by presenting recommendations succinctly in bullet-point
format and incorporating a visual aid depicting a holistic approach to patient assessment.35
An Australian study surveyed GPs (n = 79) to explore their attitudes about national and
international CPGs for the conservative management of hip and knee OA, and found that
most respondents were either unaware of the guidelines (30%), never used them (19%), or
rarely used them (34%).47 GPs expressed a strong preference for shorter, electronic, and
easily accessible formats such as one-page checklists, summaries, and flowcharts.
Several treatment algorithms have been developed to facilitate the implementation of
evidence-based recommendations in primary care.33,46,48 In 2014, the European Society for
Clinical and Economic Aspects of Osteoporosis and OA task force developed the first
detailed clinical algorithm or flowchart to guide referring physicians through the steps of
combination therapy.46 After reviewing and synthesizing existing CPGs for OA, members of
the task force (n = 13) proposed an algorithm consisting of the initial core set (education,
exercise, and weight loss) followed by four sequential, multimodal treatment steps. If the
core set fails to control symptoms, GPs are to proceed to step 1 and provide
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nonpharmacological (referral to physiotherapy, manual therapy, acupuncture, TENS, and
walking aids) and pharmacological treatment (acetaminophen and topical NSAIDs). In step
2, patients with persistent symptoms are offered advanced pharmacological modalities (oral
NSAIDs and IA injections). In severely symptomatic patients, step 3 involves the last
pharmacological attempts before surgical options are considered (duloxetine and short-term
weak opioids such as tramadol). Step 4 comprises end-stage disease management (TJA or
opioid analgesics if surgery is contraindicated). Although the benefits of acupuncture,
manual therapy and TENS are contested39,43, the authors suggest that they may be offered as
alternative treatments if surgery is contraindicated or unwanted.
A different approach was adopted by Meneses et al.33 in 2016, who assembled a
multidisciplinary panel of experts (n = 15) from eight countries to develop two case scenarios
to represent common clinical presentations of knee OA along with their corresponding
treatment algorithms. The panel, which consisted of GPs, physiotherapists (PTs),
rheumatologists and orthopedic surgeons, systematically reviewed the most recent CPGs and
selected appropriate treatments for each scenario through expert consensus. To promote a
patient-centered approach, two individuals with knee OA provided feedback throughout the
process. Similar to the task force’s four-step flowchart46, the finalized algorithms were
presented as schematic decision trees with pharmacological and nonpharmacological
treatments in parallel, culminating in referral to surgical consultation “if disabling symptoms
and if already exhausted all other options, including pharmacological and
nonpharmacological interventions.” They also consider comorbidities and contraindications,
encourage referral to a physiotherapy or occupational therapy, the use of assistive devices, IA
injections, and opioid therapy prior to referral, and go a step further than existing algorithms
by including a long-term, postoperative ET program tailored to the patient’s goals. Although
only two algorithms were developed for hypothetical scenarios, they represent common
clinical cases and thus provide practical examples of guidelines’ utility and applicability to
the primary care context.
Given GP preference for short and easy-to-use formats, treatment algorithms are promising
tools for promoting the implementation of evidence-based recommendations. However, their
impact on clinical-decision making, and ultimately patient outcomes and healthcare costs,
has yet to be determined.
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2.1.2.3 Incongruity of Guidelines with Primary Care Practice
Another possible explanation for the poor uptake of CPGs is that they lack relevance to knee
OA patients with comorbidities and thus the reality of clinical practice. Current evidence
suggests that 68% to 84% of patients with knee OA suffer from at least one other chronic
condition.49–51 A Canadian epidemiological study of primary care patients with OA (n =
29,592) found that hypertension, diabetes, and chronic obstructive pulmonary disease were
the most common conditions associated with the diagnosis of OA.51 Furthermore, a recent
systematic review revealed a high prevalence of anxiety and depression among patients with
knee OA.52 Both psychological and physiological comorbidities may serve as
contraindications to certain treatments for knee OA, contribute to noncompliance, and lead to
higher levels of pain and disability49,50,52,53, thereby posing a unique challenge to the
management of knee OA.
Despite exercise therapy (ET) being a core conservative for knee OA, GPs often hesitate to
offer it to patients with comorbidities due to concerns about aggravating the symptoms of the
other condition(s).53 Given the marked prevalence of comorbidity in patients with knee OA,
Rooij et al.53 conducted the first RCT to investigate the safety and efficacy of tailored ET on
physical functioning in this patient group compared to usual care (n = 63/group). The most
prevalent comorbidities were obesity (61%), cardiovascular disease (36%), and chronic
obstructive pulmonary disease (32%). Patients in the intervention group participated in a
five-month ET program that consisted of comorbidity-adapted aerobic and strengthening
exercises and training of daily activities under the supervision of a PT (two 30- to 60-minute
sessions per week). ET was adapted by changing the frequency, intensity, timing, and types
of exercises both pre-intervention (through an extensive assessment of restrictions and
contraindications) and throughout the intervention (by monitoring comorbidity-related
symptoms at every session). The primary outcome measures were the Western Ontario and
McMaster Universities OA Index (WOMAC) physical functioning subscale score and the 6minute walk test assessed at baseline, five months (directly post-intervention) and eight
months. The overall, between-group difference was statistically significant for both outcomes
(WOMAC: -7.43, 95% CI -9.99 to -4.87; p < 0.001; and 6-minute walk test: 34.16 meters,
95% CI 17.68 to 50.64; p < 0.001). The large between-group ES for physical functioning
observed directly post-intervention (SMD 0.9), with an even further improvement three
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months post-intervention (SMD 1.0), suggest that tailored ET programs that take the
necessary precautions are not only safe but can also greatly benefit patients with knee OA
and comorbidities.
The lack of applicability of current CPGs largely stems from the imbalance between internal
and external validity in the underlying research. Although systematic reviews and metaanalyses of RCTs provide the highest level of evidence, RCTs often exclude participants with
comorbidities, giving precedence to internal validity over generalizability.54 As a result,
guidelines rely on unrepresentative samples, thereby providing simplified treatment
recommendations that are inapplicable to a large subset of patients.
Thus, future CPGs and other efforts to improve the quality of knee OA care must explicitly
address the highly prevalent comorbidities and their compounding effect on management
options and patient outcomes by promoting a holistic and individualized approach. Although
the latest OARSI guideline acknowledges the interplay between knee OA, comorbidities and
treatment effectiveness by providing separate recommendations for four patient types43, the
broad groupings are likely insufficient for a truly personalized approach to patient care.

2.1.2.4 Limited Guidance on Multidisciplinary Management of OA
Given that knee OA is a chronic and multifactorial disease55,56 with diverse symptom
manifestation57, its effective management requires an integrated multidisciplinary approach.
While most CPGs explicitly recognize the importance of multimodal treatment pathways,
they provide no practical guidance on the coordination and delivery of care across
disciplines. Recent surveys suggested that this cultivates misperceptions among GPs about
the roles that allied health professionals play in the management of OA, thereby contributing
to the issues of suboptimal patient care and inappropriate referral to TKA.58–60
Recognizing the paucity of detailed CPGs, the EULAR expert panel developed
comprehensive recommendations for the nonpharmacological management of hip and knee
OA, in which they specified the content, timing, frequency, duration, and delivery of each
treatment.34 Although it encouraged multidisciplinary and individualized care, it provided no
advice on how various providers should collaborate and integrate their care. Similarly, the
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updated NICE guideline emphasizes a holistic approach to the diagnosis and management of
OA, yet does not clarify the roles of different providers.35
An online survey of GPs across the UK (n = 232) explored adherence to national guidelines
and barriers to providing quality care for patients with OA.58 Although most respondents
(65%) rated the NICE guidelines as the primary source of information that guided their
practice, only 15% felt that they were managing OA effectively. Similarly, approximately
half (48%) reported using educational materials with patients, yet only a third felt that their
educational material was adequate. The most commonly cited barriers to optimal
management of OA were difficulty achieving adequate pain control and a lack of time.
A similar study explored the attitudes, beliefs, and behaviors of GPs (n = 835) across the UK
regarding the use of ET for OA, including advice on general or local exercise and referral to
physiotherapy.60 Attitudes and beliefs were measured on a five-point Likert-type scale, while
behaviors were assessed using a clinical vignette of a 58-year-old female patient with her
first presentation of gradually worsening bilateral knee pain. Most GPs appeared to believe in
the safety and benefits of ET, with 87% recommending some type of exercise for the vignette
patient. However, only 5% explicitly stated that their advice would be tailored to patient’s
interests and abilities. Furthermore, reported behaviours were not aligned with the NICE
guideline, as only 11% provided written information on exercise or referred to physiotherapy.
This is not surprising, given that only 61% of GPs reported having read the national
guideline.59 Furthermore, the overwhelming majority (98%) described several barriers to ET
use, including insufficient time, a lack of expertise, and uncertainty about the most
appropriate types of exercise and the range of services offered by PTs.
These findings indicate a need for strategies to disseminate evidence-based recommendations
and clarify the roles of GPs and other providers, especially considering that both studies
likely overestimated adherence to guidelines due to response bias (given low response rates),
reliance on self-report, and a subset of GPs (8% and 6%) having a special interest (i.e.,
additional training and experience) in musculoskeletal (MSK) conditions.
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2.1.2.5 Inadequate Training in Administering Joint Injections
A considerable proportion of inappropriate referrals consists of patients who have not
exhausted conservative treatments, including IA joint injections.28 Patients with knee OA are
routinely treated with corticosteroid and HA injections61, which can be performed by a
variety of healthcare providers, including GPs, advanced practice PTs, physiatrists,
podiatrists, rheumatologists and orthopedic surgeons.62 IA corticosteroid injections may
provide short-term relief of moderate to severe pain in patients with knee OA, and are
generally recommended as an adjunct to core treatments.35,36,43,62 Although HA injections
may alleviate mild knee pain for up to 24 weeks63, current recommendations for this
procedure are inconsistent, with some guidelines advising against their use 25,35, while others
provide uncertain recommendations and encourage patient-physician shared decision-making
to determine whether they may have merit.36,43
Klett et al.26 evaluated the impact of a screening clinic for patients with knee OA referred for
TKA and identified the conservative treatments used prior to referral. Nearly half of the
patients (47%) were referred back to their GP with recommendations for nonoperative
management. Corticosteroid injections were suggested for 45% of inappropriate referrals,
while appropriate surgical candidates were significantly more likely to have tried injections
(59% vs. 32%; p < 0.001). Previous use of IA injections was also found to be predictive of
surgical appropriateness at our center, as patients who had tried injections were about 1.5
times more likely to be scheduled for TKA at their initial consultation (OR 1.79, 95% CI
0.93 – 3.43 in the training data set, and OR 1.65, 95% CI 0.86 – 3.19 in the validation
model).27 In line with these studies, Jolly and Curran64 found that primary care physicians
underused IA injections in the management of arthritis due to inadequate training and
discomfort with the technique. Physicians practicing at a university hospital (n = 55; 36
residents and 19 faculty members) completed a questionnaire querying training, experience,
and comfort in administering joint injections. Despite widely supporting the use of IA
injections for severe arthritis, only 19% of respondents had performed the procedure
themselves and most (90%) referred patients to specialists (48% referred to rheumatologists,
12% to orthopedic surgeons, and 29% to both). With a mean comfort score of 4.5 (on a scale
from 0 – 10), primary care providers cited discomfort with performing injections as the main
reason for referral requests. The overwhelming majority (95%) of respondents believed that
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their training was inadequate, and only 40% of residents had received a lecture on joint
injections in medical school or a demonstration during residency.
Given the central role that GPs play in managing knee OA nonoperatively, education and
training in joint injection techniques would enable them to perform injections. Alternatively,
simply providing access to a list of local GPs or advanced practice PTs who administer
injections may effectively eliminate a subset of unnecessary referrals to specialty care.

2.1.2.6 Misperceptions about Indications and Outcomes of TKA
The persistent lack of consensus on indications for surgery appears to be a major contributor
to the issue of inappropriate referral. Throughout the last two decades, numerous studies have
consistently demonstrated wide variations in the perceptions of physicians in Ontario
regarding patient candidacy for TKA and the risks and benefits of surgery, not only between
but also within specialties.29–31,65
In 1996, Attard et al.29 surveyed a random sample of urban and rural GPs (n = 126),
rheumatologists (n = 67) and orthopedic surgeons (n = 234) in Ontario to explore their
opinions on indications for TKA and its outcomes. Respondents rated the extent to which 32
patient characteristics (identified through a literature review and surgical expertise)
influenced their decision to refer for, or perform, TKA on a five-point Likert-type scale,
ranging from “much less likely” to “much more likely”. In addition, perceived effectiveness
of TKA was based on physicians’ estimates of the proportion of patients that would
experience various outcomes, both positive and negative. There was significant disagreement
between surgeons and GPs regarding both surgical candidacy and the outcomes of TKA. For
most of the patient characteristics, GPs were more likely to refer for surgical consideration
than surgeons were to perform TKA, whereas surgeons were more optimistic about the
effectiveness of surgery than GPs. Results also revealed physicians within specialties
disagreed on many indications for TKA (GPs disagreed on 12 of the 32 patient factors,
rheumatologists on 10, and surgeons on seven).
More recently, Wright et al.30 determined how much of this variability was attributed to
inconsistencies in the opinions of individual physicians. Similar to the previous study, GPs
(n = 165), rheumatologists (n = 111), and surgeons (n = 109) rated the effect of 34 patient
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characteristics on their decision-making about referring for, or performing, TKA. Physicians
also rated their “anxiety due to uncertainty” and “reluctance to disclose uncertainty to
patients” using a five-point Likert-type scale. To determine the reliability of individual
responses, a subset of participants (n = 186) completed the questionnaire again after six
weeks. Consistent with previous findings, physicians disagreed on indications for TKA.
However, half of the variability was attributed to disparities in their individual opinions
reported merely six weeks apart (intraclass correlation coefficient [ICC] 0.49, range 0.11 –
0.79). Despite poor inter-rater agreement, neither GPs nor surgeons acknowledged any
uncertainty in their opinions. Withholding relevant information regarding treatment
decisions, including feelings of uncertainty, reflects a paternalistic approach that prevents
patients from engaging in shared decision-making and leads to unnecessary referrals.
In 2016, Waugh et al.31 reiterated the results of these surveys, finding that the perceptions of
referring GPs (n = 212) regarding patient indicators of appropriateness and the outcomes of
TJA continue to vary widely in Ontario. This study adds to the existing literature by
providing insights into GP predictors of low confidence in determining patient candidacy for
surgery. Despite marked dissonance in reported outcomes, GPs generally overestimated both
the risks and benefits of TJA. Nearly a quarter of respondents (22%) was uncertain about the
risk of at least one major complication, while 77% overestimated the revision rate and
believed that prosthesis survivorship was <15 years. GPs reported moderate confidence
levels in deciding whom and when to refer for TJA (mean score of 6.95 on a scale from 1 –
10), and approximately half (44%) were unsure about surgical indications and identified this
as a major barrier to referral. Low confidence (i.e., score ≤6) was significantly associated
with being female (OR 2.18, 95% CI 1.06 – 4.46; p = 0.03) and reporting a lack of clarity
regarding indications for TJA (OR 3.54, 95% CI 1.87 – 6.66; p < 0.0001). Interestingly, other
factors such as clinical experience (≤15 vs. >15 years of practice), group vs. solo practice
and urban vs. rural practice, were not predictive of low confidence.
Citing the excessive wait times for TJA in Ontario, Hudak et al.65 provided an alternative
explanation for the lack of consensus on surgical indications based on the argument that
many appropriate candidates are not offered surgery. The decision-making processes that
dictate patient candidacy for TJA were explored using focus groups and in-depth interviews
with GPs
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(n = 18), rheumatologists (n = 15), and surgeons (n = 17). The findings suggested that the
decisions around surgical suitability entail more than simply identifying appropriate patients
and are influenced by system-level factors, such as limited operating room time and lack of
postoperative care. Presuming that not everyone who requires TJA will undergo surgery, the
authors argue that physicians are obliged to engage in “medical brokering” to ration limited
healthcare resources in our constrained healthcare system. With an excess number of
appropriate surgical candidates, physicians must prioritize patients and determine the best
candidates for TJA using their own criteria. This argument implies that each referral decision
constitutes a dilemma for GPs, as institutional constraints force them to adopt the role of
gatekeepers to scarce specialist services, which conflicts with their fiduciary duty to act in
the best interests of individual patients. Yet, by arguing that many suitable patients are not
offered surgery, the authors do not address the abundance of inappropriate referrals.
Nevertheless, this study reiterates the need for the development of surgical appropriateness
criteria to render the referral process more transparent and ensure equitable resource
allocation.

2.1.2.7 Failure to Engage Patients in Shared-Decision Making
Misperceptions about surgical indications and outcomes are the leading causes of the
observed uncertainty among GPs, whose hesitation to discuss the possibility of TKA with
patients results in the frequent referral of patients who do not intend to undergo surgery.
A population-based cohort study found that 66% (250 of 379) of individuals with disabling
hip and knee OA unwilling to consider TJA as a treatment option.66 Unwillingness was
strongly associated with misperceptions about indications for surgery and postoperative
outcomes. A previous study at our center found that 13.7% (28 of 203) of patients were
unwilling to undergo surgery at their initial surgical consultation, compared to 30.7% of
inappropriate referrals.27 Using a training and validation sample (n = 203/sample), the
authors developed and cross-validated a model to predict whether patients referred to TKA
were scheduled for surgery at their initial consultation. Willingness to undergo surgery was
the strongest predictor of surgical suitability. In the training sample, patients who were
willing to undergo surgery were about 4.5 times more likely to be scheduled for TKA (95%
CI 1.64 – 12.08; p = 0.003). The validation sample further supported the results, in which
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willing patients were approximately 10 times more likely to be scheduled for surgery (95%
CI 3.01 – 31.71; p < 0.001).
As a result of GPs ceding the responsibility of information provision to orthopedic surgeons,
the large proportion of referrals unwilling to undergo surgery needlessly wait for surgical
consultation, only to be redirected back to primary care management. This leads not only to
postponed conservative treatment for nonsurgical referrals, but also increased wait times for
appropriate candidates in need of TKA. Patient and GP education on surgical suitability and
the risks and benefits of TKA could therefore avoid many unnecessary referrals, thereby
improving access to specialty care.

2.1.3

Unwarranted Ordering of Diagnostic Imaging Tests

Another issue resulting from the evidence-to-practice gap in primary care is the ordering of
inappropriate imaging tests for the diagnosis of OA, specifically magnetic resonance imaging
(MRI). Between 1996 and 2006, the annual use of MRI has increased six-fold in Canada,
with GPs ordering 20% of MRI examinations.67
CPGs for the diagnosis and management of OA have evolved over time, with older
guidelines recommending plain radiographs (bilateral anteroposterior weight-bearing, semiflexed posteroanterior, lateral, and patellofemoral views).61,68 However, the latest NICE
guideline states that the diagnosis of OA be made clinically without imaging tests if patients
meet the following three criteria: (1) are ≥45 years of age, (2) experience activity-related
joint pain, and (3) either experience no morning joint-related stiffness or morning stiffness
that lasts <30 minutes.35 The American College of Radiology and Canadian Association of
Radiology have also published national practice guidelines that provide indications (by
imaging modality and by organ system) to assist providers in ordering appropriate imaging
tests.69,70 MRI is generally not indicated for the diagnosis of OA, but may be useful if a rare
condition is suspected (e.g., osteochondritis dissecans, avascular necrosis, or pigmented
villonodular synovitis).68,71 Despite clear evidence-based recommendations for the ordering
of diagnostic imaging tests, MRI has been increasingly used to diagnose knee OA in primary
care leading to increased costs and wait times.72
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A retrospective review of elective outpatient computed tomography (CT) and MRI
examinations ordered by GPs in the US found that 14% the knee MRI scans (5 of 36) were
unwarranted according to evidence-based appropriateness criteria.73 Similarly, a US study of
new referrals presenting with knee pain (n = 599) to an academic orthopedic sports medicine
clinic found that nearly a quarter of patients (22%) underwent MRI prior to referral, often
without having preexisting weight-bearing radiographs.74 Only 58% of patients had obtained
plain radiographs before MRI, of which just 13% were appropriate (i.e., weight-bearing).
Orthopedic surgeons evaluated the results of the weight-bearing radiographs, which were
ultimately obtained for all participants, as well as the appropriateness of pre-referral MRI.
Among patients whose radiographs revealed >50% joint space narrowing, almost all MRI
scans (95%) were deemed unnecessary and had no impact on treatment recommendations.
On the other hand, some studies have argued for the diagnostic utility of MRI in detecting
early, pre-radiographic OA. The review by Favero et al.75 suggests that MRI is important for
earlier diagnosis of OA given its ability to detect structural changes not only in the
periarticular bone and cartilage, but also in the menisci, synovium, and ligaments. The
authors argue that, by visualizing cartilage defects and bone marrow lesions, MRI can
identify patients at a high risk of OA progression and enable early initiation of preventative
management. Given that conservative treatments may effectively relieve symptoms in the
early stages of OA, appropriate and timely diagnosis offers an opportunity to influence
modifiable risk factors to prevent the later degenerative changes that would have already
occurred once OA is detected clinically or radiographically.62 This is especially crucial for
alleviating pain and maximizing the QoL in younger patients, for whom surgical options are
limited. However, a systematic review and meta-analysis of studies evaluating the diagnostic
performance of MRI in OA concluded that its sensitivity is below that of clinical and
radiographic diagnoses.72 Given that the latter are more cost-effective and considered the
diagnostic standard, the use of MRI for the routine diagnosis of OA is unjustified. In addition
to often being clinically irrelevant, MRI findings may also lead to futile treatment. Incidental
meniscal tears are common in older people, including those without any symptoms and
patients with painful OA.74 Thus, the overuse of MRI can result in the increased detection of
meniscal tears and unnecessary arthroscopic knee surgery in asymptomatic individuals.71
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Given the recent increase in wait times for CT and MRI in Ontario, You et al.76 explored
physicians’ attitudes about the use of these imaging tests. Through one-on-one teleconference
interviews with GPs, specialists and radiologists (n = 19), the authors identified two
predominant issues: (1) non-clinical reasons for ordering scans, and (2) communication
among physician groups. Non-clinical reasons for ordering CT and MRI scans included
practicing “defensive medicine” (fear of being sued for a delay in diagnosis), indeterminate
imaging reports (which make written recommendations for further diagnosis), patient
demand (ordering tests to satisfy or reassure patients), supply-induced demand (improved
access to CT and MRI driving increased patient demand and expectations), and significant
variation in ordering practices within specialties (indicating variation in perceived indications
for imaging tests). The second theme reflected participants’ feelings of increasing isolation
between ordering clinicians and radiologists (due to poor written and verbal communication),
as well as GPs and specialists working in solos (as each physician group blamed the other for
the overuse of CT and MRI scans). With only 19 participating physicians, these findings are
preliminary; however, they shed light on several deficiencies of the current healthcare system
and reiterate the need for patient and physician education as well as strategies to facilitate
inter-disciplinary communication.

2.1.4

Inefficiency of Current Referral Systems

Appropriate and timely access to specialty care requires informative and efficient
communication among providers. However, national physician surveys suggest that current
referral systems have much room for improvement. The significant variation in referral
processes between, and even within, specialties and geographic areas contributes to the poor
access to specialty care.
National physician surveys were conducted to identify the main shortcomings of existing
referral systems across Canada. The CMA drafted a policy statement77 regarding referral and
barriers to accessing specialty care based on the results of an unpublished 2012 survey78 of
GPs and specialists (n = 3,000). The 2010 National Physician Survey79 consulted GPs (n =
6,602) and other specialists (n = 32,096) across Canada about sending and receiving referral
requests. Both surveys revealed widespread dissatisfaction and considerable variation in
referral request processes. Results suggest that specialists differ in their requirements for
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accepting referral requests (e.g., use a specific referral form or communication method),
while referring physicians vary widely in the quality of information provided in referral
requests (i.e., the degree to which information is sufficient, up-to-date, and relevant). There
was a notable discrepancy in perceptions of referral request completeness; the vast majority
of GPs felt that they provided all the necessary information, whereas less than half of
specialists agreed (91% vs. 47%). Among all physician groups, GPs were the least satisfied
with the referral process, with only 43% considering it effective.78 Many GPs (67%)
identified at least one issue involving insufficient information as a major source of frustration
(e.g., not being informed by specialists about referral receipt, patient’s appointment,
treatments plan, and requested services not being offered).78 On the other hand, over half of
all specialists (53%) reported frustration with the lack of information in referral requests
(e.g., regarding test results, reason for referral, and previous treatments).79
Inadequate information provision and a lack of standardization in the current referral process
is problematic. e-Referral systems would effectively address these issues by streamlining the
referral process and facilitating inter-provider communication, thereby improving referral
efficiency and ultimately access to specialty care.

2.2 Strategies to Bridge the Evidence-to-Practice Gap
The literature suggests that issue of excessive wait times for TKA largely results from
suboptimal primary care and inefficient referral systems. Improving access to specialty care
requires the development of innovative models of care. Given the paradigm shift in modern
medicine towards electronic interactions, we proposed a NRP that engages patients and GPs
to streamline the referral process. We must therefore consider the theoretical underpinnings
of KT and elucidate the factors that may impact is uptake and sustainability.

2.2.1 Knowledge Translation
At the Canadian Institutes of Health Research (CIHR), KT is defined as “a dynamic and
iterative process that includes the synthesis, dissemination, exchange, and ethically sound
application of knowledge to improve the health of Canadians, provide more effective health
services and products, and strengthen the healthcare system.”80 Graham and Tetroe81 –
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leadings KT experts at the CIHR – acknowledge that the healthcare system consists of
complex interactions among researchers, policymakers, healthcare providers, administrators
and patients. As such, they argue that bridging the “knowledge transfer gap”, or transferring
research findings into practice, is often a slow and disorganized process, and recommend that
it be guided by theories or frameworks. To support practice change efforts, the authors
conducted a focused literature search and identified 31 planned action theories, which are
models that rationalize and systematically structure activities to cause change. The theory
analysis of these models revealed many common action steps: identifying the problem,
identifying the target audience, assessing barriers to using the knowledge, reviewing
evidence, tailoring interventions, implementing the program, and evaluating the process and
outcomes. The knowledge-to-action cycle was derived from these results and illustrates the
interconnected elements of KT centered around knowledge creation and action/application
(Figure 1).

Figure 1: Knowledge-to-action cycle
Adapted from Graham et al. Lost in knowledge translation: time for a map?, The Journal of
Continuing Education in the Health Professions, Vol. 26(1), pp. 13-24, 2006.82
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Dobbins et al.83 conducted a RCT to evaluate the impact of three KT strategies on the
incorporation of research evidence into policies and programs focused on healthy body
weight promotion in a national sample of public health departments across Canada (n = 108).
The chosen KT strategies are commonly used to promote evidence-based decision-making
and include: (1) access to web-based resources that summarize research evidence, (2) tailored
and targeted messages, which deliver relevant evidence to specific decision-makers, and (3)
knowledge brokers, who work one-on-one with decision-makers to promote knowledge
transfer. Tailored and targeted messages was found to be the most effective KT strategy,
especially in health departments that perceived their research culture as high (i.e., placed
greater value on using research evidence in decision-making). This suggests that, while
tailored and targeted messages may increase the uptake of research evidence, it is important
to consider organizational factors to ensure that strategies are well-suited to target users’
needs.
The poor uptake of CPGs for the management of knee OA in primary care indicates the
importance of considering the needs of end-users and engaging them in the guideline
development process. Tackling excessive wait times for TKA is a complex undertaking that
requires the collaboration of key stakeholders (i.e., healthcare providers, patients, and
hospital administrators) to achieve mutual understanding of their different perspectives and
priorities. Gagliardi et al.84 describe that, in integrated KT (iKT), stakeholders are involved
throughout the entire research process, from identifying the research questions to
disseminating the results. The ongoing partnership among researchers, policymakers,
clinicians and patients in iKT is more likely to generate knowledge that is practical and
relevant to the target knowledge users. iKT is a dynamic process that is influenced by
contextual factors and facilitated by establishing clear expectations from all stakeholders to
avoid misunderstanding and role confusion. Thus, iKT holds considerable promise for
addressing the shortcomings of current CPGs and ultimately improving the quality of care for
patients with knee OA.
Finally, it is widely acknowledged that the Internet has become a central element of KT.83,85
The Internet allows health consumers to access a broad range of health-related information,
from unaffiliated websites to scientific journals and online resources that compile and
summarize the best available evidence on diverse health topics (e.g., MedlinePlus, DailyMed,
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health-evidence.ca, etc.). By enabling rapid and widespread dissemination, the Internet
provides an unparalleled platform for new KT strategies to reach their target audience.

2.2.2 e-Learning
Since the 1980s, the term “e-learning” has been used to describe web-based education.86 In
general, e-learning is an umbrella term for training and education that occurs via digital
media using various instructional formats (e.g., applications, programs, websites, etc.) that
enable independent, asynchronous self-study.87 Asynchronous e-learning can occur at any
time and place and involves self-directed learning, obviating the need for a human
facilitator.88 Asynchronous e-learning has many advantages, including easy access,
flexibility, convenience, and lower costs compared to face-to-face learning.88 However, it
also has several disadvantages, such as the need for sustained motivation to engage in selfstudy, lack of peer interaction, and inability to ask questions.88 With the power of technology
and a thorough understanding of contextual factors, we can provide engaging web-based
learning experiences to effectively disseminate research evidence and meet the needs of
individual learners (e.g., patients and clinicians) and institutions (e.g., universities, hospitals
and healthcare systems).

2.2.2.1 Continuing Medical Education
Despite the growing popularity of e-learning in medical education, research in this area is in
its early stages. Few studies have evaluated the outcomes of e-learning, and existing
systematic reviews focus mainly on specific medical disciplines, such as pediatrics87 and
orthopedic surgery.89
A recent integrative review by Lawn et al.88 evaluated the available literature on e-learning
for self-management support (SMS) training of healthcare professionals managing patients
with chronic conditions. SMS training focuses the development of skills required for patientcentered care, including patient education and support with goal-setting, motivation and
behaviour change. The authors identified 10 peer-reviewed studies (quantitative, qualitative,
and mixed methods) and derived seven major themes from their findings using content
analysis (Table 2). Findings revealed considerable heterogeneity in the format and features of
the e-learning packages. This variation, coupled with the limited number of available studies,
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indicates that the optimal e-learning methods for training healthcare professionals in the
range of skills needed to manage chronic conditions remain unclear. However, all studies
emphasized the importance of considering the context and providing practical, real-life
examples.

Table 2: Themes identified in a review of studies on e-learning for the training of
healthcare professionals in self-management support provision to patients with chronic
conditions
Themes

Description

1. Participants and
professions

Studies included a range of healthcare providers (nurses, GPs,
GP residents, specialists, and allied health professionals).

2. Timeframe of
e-learning package

The duration of e-learning packages varied among studies, but
most consisted of multiple short sessions (20-30 minutes).

3. Content of
e-learning package

The e-learning content varied and included a broad range of
SMS capabilities (e.g., problem-solving, action planning,
motivational interviewing, and goal-setting).

4. Guiding theoretical
framework

Most studies (7 of 10) used behavioural change theories to guide
the development and delivery of the e-learning package.

5. Outcome measures

Surveys and semi-structured interviews were most commonly
used to evaluate learning and focused on short-term, subjective
outcomes (e.g., patient satisfaction, intention to change practice,
and perceived practice change).

6. Instructional design
(e-learning features
and format)

Various e-learning formats were used (webinar, online videos,
interactive modules, and scenarios), all striving to provide an
interactive and engaging learning experience that was applicable
to practice.

7. Barriers to
e-learning

All studies identified several barriers (e.g., computer literacy
skills, access, time, and limited space), yet few proposed
solutions.

One of the studies included in this integrative review was an Australian pilot study, which
developed, implemented and evaluated a multidimensional learning package to improve the
understanding of GP registrars or residents (GPRs) regarding their role in providing SMS and
lifestyle risk modification (LRM) specifically for patients with OA.90 A pretraining survey
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revealed a dichotomy between GPRs and their supervisors in perceptions of the importance
of SMS and LRM skills, which are increasingly considered necessary for providing optimal
patient care for patients with knee OA and other chronic conditions. Of the 40 GPRs, the vast
majority (82.5%) considered themselves either well or very well prepared in providing SMS
and LRM. On the other hand, interviews with GP supervisors (n = 13) revealed that most
were unfamiliar with the core aspects of these skills and did not view them as learning
priorities for GPRs. The online learning package or module was based on several health
promotion principles, including structural problem-solving and action-planning, health
behavior change models, and multidisciplinary learning and practice. The module divided the
learning material into 3 areas using the concept of “rooms”: (1) the library room provided
readings, references, websites and guidelines, (2) the consultation room contained interactive
case studies where GPRs could engaged in short interactions with patients (≤20 minutes)
both online and in an interactive workshop, depending on GPRs’ preferred learning styles,
and (3) the project room provided GPRs with three investigative approaches (patient
education, practice quality improvement, and learning from patients) to further develop their
understanding of SMS and LRM. The module also included self-assessment quizzes to allow
GPRs to test their newly acquired knowledge. The authors found that parts of the website
were not used to their full capacity, particularly the reading materials. Of all activities, GPRs
most frequently accessed the quizzes, commenting on the usefulness of immediate feedback
in channeling their learning. Given that only nine GPRs completed the online module, no
definitive conclusions can be drawn from these preliminary findings. However, they indicate
a preference for short, interactive learning activities and immediate feedback. They also
further support the importance of considering the context; in this case, the discrepancy
between GPRs and their supervisors in the perceived importance of the SMS and LRM skills
may prevent GPRs from engaging in the e-learning program.

2.2.2.2 Multidisciplinary Chronic Care
The observed evidence-to-practice gap and clinical uncertainty in the primary care
management of knee OA indicates a need for improved guidance and coordination of
multidisciplinary care. The inability to adequately control pain – the predominant symptom
of knee OA – is a major challenge faced by GPs and a common reason for premature referral
to TKA.58 While knee OA is typically characterized by a transition from intermittent, acute
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pain to chronic pain91,92, it is highly variable and complex.55,93 Recent insights into the
mechanisms of knee OA pain suggest that this transition involves increased sensitivity to
pain (due to chronic inflammation leading to peripheral and central sensitization of the
nervous system), neuropathic pain, as well as psychological and social factors (e.g., low selfefficacy, lack of social support, etc.).24,55,56,94–96 Furthermore, the interaction between
comorbidities and chronic pain perpetuates a vicious cycle potentially leading to detrimental
patient outcomes. For instance, anxiety, depression, and diabetic neuropathy, which shares
common neuropathic processes with OA, can aggravate the perceived experience of OA
pain.52,55 Given the high prevalence of comorbidities among patients with knee OA49–51,
successful management requires a holistic and multidisciplinary approach, as well as ongoing
patient feedback to determine optimal pathways for the tailored delivery of core treatments
(education, pharmacotherapy, nutrition counselling, physiotherapy, occupational therapy, and
psychological support).
A new model of care is needed for chronic pain management that considers the psychosocial
determinants of health and involves other healthcare professionals playing active roles. PTs
have emerged as pivotal providers in enhancing the management of OA, particularly through
ET and behavioural change programs.57,97 Furthermore, advanced practice PTs, who receive
additional training to extend their scope of practice, are able to diagnose and treat patients
with OA, as well as perform injections and refer them for TJA.98 Studies have shown that
advanced practice PTs may provide care with equal or better effectiveness and reduce wait
times for arthroplasty, while containing costs and achieving high patient satisfaction.98,99
GPs have identified interdisciplinary collaboration and training as major needs for improved
OA management.58,60,64 Interdisciplinary educational workshops have been shown to be
effective for translating arthritis CPGs into practice100 and improving skills and comfort
levels in administering IA joint injections.101 Although such workshops allow for the
development of hands-on skills and interdisciplinary learning, they require expert instructors
and a significant amount of time and resources. Information technology, however, offers a
promising alternative platform for GP education that has the advantage of convenience,
accessibility, and lower costs.
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2.2.2.3 Computer-Based Patient Education
In conjunction with supporting GP clinical decision-making, educating patients lies at the
core of the proposed NRP. Current literature focuses primarily on e-learning in continuing
medical education for healthcare providers. However, the importance of patient education in
improving health outcomes and reducing costs is widely acknowledged.102–104 This, coupled
with GPs’ self-reported lack of time, inadequate information provision, and ineffective
management of OA58,60, calls for the development of innovative strategies to empower
patients to engage in shared decision-making and play an active role in making choices
related to their treatment.
There is a strong body of evidence supporting the use of patient education technologies. A
Cochrane review of computer-based patient education programs for patients with chronic
conditions reported improved patient knowledge, health outcomes, and feelings of selfefficacy and social support.102 One of the first systematic reviews to evaluate the impact of
such programs concluded that it is an effective strategy for knowledge transfer and selfmanagement skill development.105 Improvements in outcomes (Cohen’s d ES ≥0.5) were
found in most of the identified studies (17 of 21), even among elderly patients with little
computer experience. Interactive video or CD-ROM programs were the most commonly used
delivery strategies. While most of the studies suggest that computer-based approaches are
effective in delivering patient education, few measured patients’ long-term retention of
knowledge or skills.
One of the studies included in this review focused specifically on the computer-based
education of patients with OA.106 In this study, a multidisciplinary team consisting of two
rheumatologists, a GP, a PT, a nurse practitioner (NP), a sociologist, and an educator
developed eight lessons on the treatment and self-management of OA (Introduction to the
Computer, Overview of the Disease, Medication, Exercise, Coping and Relaxation,
Quackery, and Home Helps). A staff artist then created computer graphics and converted the
text into storyboards. Participants (n = 72) field-tested the three-hour educational program
and completed a questionnaire pre-test and one week post-test, which assessed the following
four outcomes: (1) knowledge (using previously validated general arthritis and OA
questionnaires), (2) frequency of behaviours (heat application, relaxation, exercise, rest,

29
massage, or swimming), (3) attitudes about the causes of OA (using multidimensional health
locus of control scales107), and (4) satisfaction with the lessons.
Statistically significant outcomes included increased knowledge (ES 0.94) and frequency of
three of the six behaviours: exercise, (ES 0.64), rest (ES 0.53), and heat application (ES
0.49).105 Most participants (>85%) reported that the lessons were easy and enjoyable, that
they learned a considerable amount, and would recommend them to a friend. The authors
concluded that a computer-based education program significantly increased the knowledge
and motivation of older individuals with OA, who could navigate it with little need for
assistance, However, there is a high risk of sampling bias given that a convenience sample
was recruited through advertisements in senior home community centers and consisted of all
white, and mostly female (85%) participants. Nevertheless, the findings suggest that
computer-based patient education was, at the very least, feasible in 1987, suggesting that
modern-day circumstances would likely facilitate the implementation and uptake of
electronic platform.
Research evidence on the topic e-learning for patients with OA is sparse, and thus the
optimal methods of delivering web-based education remain unknown. Further research is
needed to determine what instructional formats would effectively promote KT.

2.2.2.4 Patient Decision Aids
A Cochrane review of RCTs (n = 115) found that PtDAs improved patients’ knowledge
about treatment options and their associated risks and benefits, as well as reduced “decision
conflict” (i.e., increased engagement in shared decision-making) by clarifying patients’
values and enabling them to make informed decisions.108 To guide the development,
implementation and evaluation of PtDAs, the International Patient Decision Aid Standards
(IPDAS) Collaboration developed a comprehensive checklist109 and instrument110 consisting
of quality criteria focused on three areas:
(1) Content: to evaluate whether PtDA provides structured guidance, sufficient information
on options and outcome probabilities, and adequate methods for clarifying patients’
values
(2) Development process: to assess methodological rigour, risk of bias, use of plain and
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comprehensible language (Internet-based PtDAs must meet additional criteria)
(3) Effectiveness: to determine whether PtDA improves decision quality (i.e., ensures
patients’ decision-making is informed and consistent with their values and goals)
Stacey et al.111 conducted a pilot RCT to evaluate the feasibility and potential effectiveness
of a PtDA for patients considering TKA in improving knowledge and decision quality.
Patients with knee OA (n = 340) were recruited from an orthopedic intake clinic in a tertiary
hospital in Eastern Ontario. A sports medicine specialist pre-screened new referrals for
surgical eligibility using the seven-item Western Wait List Hip Knee Priority Tool112 (WWLHKPT), mapping them onto three criteria for TKA (moderate to severe pain, moderate to
severe functional limitations, and abnormal radiographic findings). Almost half of the
patients (47%) were assessed to have milder OA and referred back to their GP with
recommendations for conservative treatment. This is similar to the proportion of
inappropriate referrals previously found at our center28 and consistent with other studies.26,113
The remaining patients were randomized to the PtDA intervention or usual education group
(n = 71/group). The PtDA consisted of a 50-minute video and a booklet with information on
different treatment options (lifestyle changes, pain medications, injections, complementary
therapies, and surgery). Risk and benefit probabilities and video-clips of patients’
testimonials were provided for each treatment option. The PtDA met most of the IPDAS
criteria for content (12 of 15), development process (8 of 9), and effectiveness (1 of 2).
Surgeons received a one-page preference report for each patient that combined the
questionnaire’s results with the clinical assessment findings. Patients in the usual education
group received a standard information booklet created by the participating hospital for all
patients undergoing TJA, which included information on preparing for TJA, recovery, and
discharge (no information on the risks and benefits of surgery or other treatment options was
provided). Subsequently, surgeons received a half-page summary of the patient’s clinical
assessment findings. Outcomes were measured using a user-friendly questionnaire based on
the IPDAS, which evaluated knowledge, values, preferred treatment choice, and decisional
conflict. Knowledge was measured using four multiple choice questions from the Hip-Knee
OA Decision Quality Instrument (OA progress over time, need for revision TKA, proportion
of patients with reduced pain, and length of recovery).114 Decision quality was deemed
adequate if a patient scored ≥66% on the knowledge test (the threshold score of 66% was
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chosen based on previous trials of PtDAs). Decisional conflict was measured using a fouritem version of the SURE tool, which assessed whether patients felt sure about the best
choice, knew the risks and benefits of each choice, were clear about what risks and benefits
mattered most, and had enough support and advice to make an informed decision.115 At two
weeks, PtDA recipients had significantly higher knowledge (71% vs. 47% of controls; p <
0.0001) and decision quality (56.4% vs. 25.0%; p < 0.001) regarding treatment options. At
the end of the one-year follow-up period, 13% of participants were still on the waiting list.
The difference between groups in the proportion of patients who underwent surgery was not
significant (9.1%, 95% CI -5.3% – 23.5%; p = 0.2165). While the preliminary findings
suggest that PtDAs are promising tools for improving patient knowledge and decision
quality, this study included only those patients deemed eligible for surgical consultation by a
sports medicine specialist. Given that the PtDA provided information on nonoperative
treatment options, it may have been more appropriate to recruit all patients rather than only
those with greater OA severity.
Following this pilot trial, Stacey et al.116 conducted a RCT to evaluate the effectiveness of
PtDAs compared to usual education on timely and appropriate access to TJA among patients
with both hip and knee OA. Patients were recruited from two orthopedic screening clinics: an
academic teaching hospital and a large community hospital. Similar to the pilot trial, patients
were pre-screened by either a sports medicine specialist (at the academic site) or by an
advanced practice PT or NP (at the community cite) using the WWL-HKPT. Patients deemed
appropriate surgical candidates (343 of 956; 36%) were referred to an orthopedic surgeon
and randomized to the PtDA intervention (n = 174) or the usual education control (n = 169).
The primary outcome was the average wait time between screening and initial surgical
consultation. Secondary outcomes included decision quality, decisional conflict, realistic
expectations of outcomes, and surgery rates within two years. The PtDA intervention was
associated with shorter wait times (hazard ratio 1.25, 95% CI 0.99 – 1.60; p = 0.0653). The
median wait time was three weeks shorter among PtDA recipients in the community clinic,
but there was no difference at the academic site. More patients in the intervention group
achieved good decision quality (56% vs. 45% of controls, relative risk [RR] 1.25, 96% CI
1.00 – 1.56; p = 0.050), and fewer underwent surgery within two years (73% vs. 81%; RR
0.91, 95% CI 0.81 – 1.03; p = 0.121). Although the PtDA intervention was associated with
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improved knowledge and decision quality, as well as fewer patients electing to undergo
surgery and shorter wait times at the community hospital clinic, the overall effect was not
statistically significant.
Given the discrepancies in the findings between the two surgical screening clinics, Boland et
al.117 conducted a subgroup analysis of knee OA patients from this RCT (n = 242), positing
that different pre-surgical assessment approaches may have influenced outcomes. At the
academic teaching hospital, a sports medicine specialist conducted a 15- to 20-minute presurgical evaluation, compared to a 45- to 60-minute assessment by an advanced practice PT
or NP at the community hospital site. To better understand the optimal circumstances for
PtDA use, the authors compared the effects of the intervention on decision quality, decisional
conflict, surgery rates and wait times between the two sites. At two weeks, PtDA recipients
were more likely to make better quality decisions than controls at the academic site (54% vs.
35%; RR 1.53, 95% CI 1.00 – 2.33; p = 0.044), whereas there was no difference between
groups at the community site (47% vs. 51%; RR 0.93, 95% CI 0.64 – 1.86; p = 0.71). Fewer
PtDA recipients at the academic site experienced decisional conflict (13% vs. 23%; RR 0.62,
95% CI 0.43 – 1.00; p = 0.05), while the opposite was observed in the community clinic,
where more PtDA users experienced decisional conflict (40% vs. 24%; RR 1.68, 95% CI
0.95 – 2.96; p = 0.08). There was no significant difference between the two sites in the effect
of the intervention on two-year surgery rates or wait times. Given that the intervention was
associated with improved decision quality and reduced decisional conflict at the academic
site but not at the community clinic, PtDAs appear to be more useful when extensive presurgical evaluation and counselling are unavailable or unfeasible.
By improving patients’ knowledge and expectations prior to surgical consultation, PtDAs
have the potential to reduce the demand for TKA by preventing the over-referral of patients
who are unwilling undergo surgery. Such decision support tools may be particularly useful in
settings where the length of pre-surgical evaluation is limited.
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2.2.3 Wait Time Management Strategies
Although the federal ministry of health identified reducing wait times for TJA as a key
priority5 and developed wait time benchmarks4, no strategy had been proposed at the national
level. As a result, provinces have piloted and implemented a variety of WTMS, such as
presurgical screening and prioritization tools and central intake systems. Given that current
studies focus predominantly on the development and implementation of different strategies,
little is known about their sustainability and long-term implications.
Pomey et al.118 described five different WTMS that have been implemented across Canada
and identified the contextual and organizational factors affecting their success and
sustainability using a conceptual model. This model encompasses four dimensions that can
impact the success of WTMS at both local and systemic levels: governance, culture,
resources, and methods/tools. The authors found that the following factors were essential for
a sustainable WTMS: financial incentives, strong leadership, collaboration between
managers and clinicians, consideration of the entire continuum of care, and an organizational
culture that cultivates innovation.

2.2.3.1 Central Intake and Assessment Clinics
In 2004, the Ministry of Health and Long-Term Care (MOHLTC) announced its new agenda
to transform Ontario’s healthcare system to ensure sustainability and improve access to care.5
Subsequently, 14 Local Health Integration Networks (LHINs) have been created across the
province to manage the integration and delivery of health care services at the local level.119
As part of the ministry’s agenda, LHINs have been mandated to develop central intake and
assessment clinics (CIACs) to coordinate and streamline the referral process using
centralized triage and/or pooled wait lists.77 CIACs allow referring clinicians to send referral
requests to one central location rather than to specific surgeons, where allied health
professionals screen and triage referrals based on a standardized process.120
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While CIACs may reduce unnecessary referrals, they create an additional, costly point of
contact between primary and specialty care. Furthermore, the 2014 CMA Policy Statement
argues that there is no single optimal method to improve access specialty care, and that a
combination of strategies should be implemented (e.g., standardized referral pathways, CIACs,
physician directories.77 Thus, the NRP may serve as an adjunct to CIACs to reduce wait times
for surgical consultation by educating GPs on appropriate and timely referral to TKA.

2.2.3.2 Single-Entry Model of Referral
Damani et al.21 described insights from the implementation of the Winnipeg Central Intake
Service (WCIS) – a single-entry model of referral to reduce wait times for TJA in Manitoba.
Single-entry models are WTMS that aim to streamline the referral process and patient flow
by pooling waiting lists, providing services through a centralized access point, and referring
patients to the next available surgeon.120 The key features of the WCIS included
standardization (of the referral form, pre-consultation patient questionnaire, screening
criteria, and rules for surgeon participation and referral allocation), an electronic waitlist
tracking tool, patient education prior to surgical consultation (via pamphlets, booklets, online
videos, and in-person classes), and monitoring of surgical performance and patient outcomes.
All members of the WCIS project team (n = 13) participated in semi-structured interviews
during and one year after its implementation and described the successes, barriers and
unexpected consequences. Overall, the team felt that the four pre-specified implementation
objectives were met: (1) the WCIS centralized the referral process, (2) approximately half of
the patients were referred to the next available surgeon, (3) screening and allocation of
referrals based on surgical capacity reduced the variation in wait times between surgeons,
and (4) the electronic waitlist tracking tool improved the accuracy of measuring referral
volumes and wait times. Despite the initial poor uptake and mistrust among GPs and
orthopedic surgeons, the authors reported that weekly one-on-one communication promoted
their understanding and cooperation. Despite this, some GPs and surgeons continued to use
their former referral systems. Overall, simplified referral request forms and clearly defined
screening criteria appeared to reduce the number of inappropriate referrals and wait times for
surgical consultation. The authors emphasized that early involvement and ongoing,
transparent communication with key stakeholders is imperative for trust and cooperation.
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Despite promising results, this case study lacks quantitative outcome measures and draws
conclusions based on a single initiative and the experiences of a small project team, thereby
providing limited evidence to support this referral model. Furthermore, the WCIS was
evaluated through a narrow lens, without considering the perspectives of key stakeholders
(i.e., GPs, surgeons, and patients). Nevertheless, the authors’ detailed description of the
design and implementation process may provide valuable guidance for future WTMS.

2.2.4 e-Referral Systems
While limited research has been done on the effectiveness of e-referral in reducing the
demand for TKA, some qualitative studies have explored patient satisfaction with the ereferral process and identified factors that influenced the implementation of various e-referral
systems.
In 2013, the Health Quality Council of Alberta published a study on the continuity of patient
care, in which it strongly recommended the development of a single provincial e-referral
system to standardize the workflow of all specialty services.121 The proposed system would
allow referring physicians to submit referral requests, track referral status, receive postconsultation specialist reports, and view the estimated wait times for consultations, tests and
procedures. In addition, a separate portal would enable patients to receive notifications about
their referral status and scheduled appointments, find appropriate contact information in case
of a problem, and view their lab results, imaging and procedure reports, and hospital
discharge summaries. Following this recommendation, several e-referral systems have been
proposed or piloted in Alberta. In 2016, the Health Quality Council of Alberta initiated a
project to elicit patient perspectives on the e-referral process and understand how it impacts
patient care.122 Using purposive sampling, the authors recruited patients of different ages and
backgrounds (n = 35) to participate in five focus groups. A constant comparative analysis of
the focus groups revealed many similarities in participants’ perspectives and experiences that
were grouped into five main themes (Table 3).

36
Table 3: Patient perspectives on e-referral systems in Alberta
Theme

Description

1. Overall
experience with
the referral
process

Many participants criticized the lack of information and
communication at various stages of the referral process. Common
problems included referrals being sent to the wrong specialist and
urgent referrals not being treated as such. A few positive experiences
were also reported (e.g., wait times being shorter than expected).

2. The ideal ereferral system

When asked to describe the ideal e-referral system, participants across
groups identified many similar key elements (Table 4) and emphasized
the importance of patient feedback throughout its development and
implementation.

3. Important
information
throughout the
referral process

Receiving the following information was most commonly rated as
“very important”: whom to contact in case of a problem, expected wait
times for appointments, the results of consultations/tests/procedures,
and how to prepare for consultations/procedures.

4. Benefits,
concerns, and
communication
preferences

All participants, even those without online access, felt that the benefits
of an e-referral system far outweigh any drawbacks. Despite overall
support, two key concerns were voiced: (1) system security and privacy
of health information, and (2) availability of other communication
options (especially for patients without electronic devices). All but one
participants preferred to receive communication via email or text
messaging (one preferred phone calls or postal mail).

Participants widely supported having online access to track their
5. Online access to
referral status and view relevant health information. Some felt this
referral status
would empower patients and allow them to become more involved in
and information
their care.

37
Table 4: Characteristics of an ideal e-referral system
Characteristic
User-friendly layout
Transparency

Adequate
information
Bidirectional
communication
Fairness

Description
The system should be robust and easy to navigate.
Patients should be informed about expected wait times and their
referral status at all times and have access to a “paper trail” that
can be printed.
Patients should know whom to contact for follow-up or in case of
a problem, be informed about their appointment dates promptly,
and receive instructions on how to prepare for consultations, tests
and procedures.
Patients should be able to indicate that they have received and
understand the information provided.
Urgent referrals should be prioritized.

Flexibility

Patients should be able to change appointment dates, have some
say in where they are referred, and be notified about opportunities
for earlier appointments.

Central repository
of information

Patients should have online access to test results as soon as they
are available and be able to share personal health information with
new physicians.

The findings from this cross-section of patients in Alberta suggest that, although e-referral
systems are highly supported, there is much room for improvement. According to the
participants, an ideal e-referral system is transparent and fair, allows for clear
communication, and provides access to information at all stages of the referral process.
Given the small sample size, these results are preliminary and require further validation.
However, they provide insights into patient perspectives on e-referral that are useful for
guiding the development of our NRP.
In the US, Delphine et al.123 interviewed the leaders of diverse healthcare organizations to
identify the drivers, barriers, facilitators, and evaluation methods of e-referral and/or
consultation systems. Participants (n = 16) were recruited using a limited snowball sampling
approach and represented a range of organizations at different stages of system
implementation, including academic medical centers, health plans, public healthcare delivery
systems, and community health networks. The authors specified that an e-referral implies an
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expectation that the specialist will see a patient, while an e-consultation does not. Although
both allow for pre-consultation communication between specialists and referring providers,
only e-consultation systems encourage ongoing, electronic co-management of patients.
Integrated e-referral and consultation systems combine the two and do not require the
referring provider to distinguish referral requests from consultations. For the purposes of our
study, we will only focus on the e-referral (n = 5) and integrated systems (n = 5) given their
relevance to our proposed NRP. In the participating organizations, both types of systems
allowed referring GPs and clinic coordinators to track referrals and were either integrated
into the electronic medical record or used standalone platforms. GPs submitted referral
requests using a free text form or a structured template with embedded referral guidelines. In
the e-referral systems, administrative assistants reviewed referral requests and allocated them
to appropriate specialists, whereas in the integrated systems, GPs submitted referral requests
to designated specialists, who determined whether patients should be seen in person or could
be managed by e-consultation alone.
Participants cited different barriers, facilitators and reasons for implementing e-referral vs.
integrated systems. E-referral systems were primarily implemented to enhance functional and
tracking efficiency, whereas the main drivers of integrated systems were poor inter-provider
communication and access to specialty care. The main factors contributing to the uptake of ereferral systems were engaged leadership of high-level executives (e.g., Chief Medical
Officers) and physician champions, while provider incentives and user-friendly platforms
were the main facilitators of integrated systems. Participants identified that GP resistance to
change was the main barrier to implementation. From the outset, all systems evaluated the
volume of referrals, number and type of specialty services available, number of referring
primary care sites and providers, and time from referral to consultation. Overall, a consistent
finding across organizations was that the successful uptake of all systems required funding,
provider incentives, as well as executive and physician leadership. Given that the leaders of
diverse organizations at different stages of system implementation reported similar drivers,
barriers and facilitators, these findings are likely relevant to many healthcare contexts.
Despite the increasing implementation of e-referral systems, research in this field is in its
early stages. The existing qualitative literature suggests that e-referral systems hold great
promise for streamlining the referral process and reducing wait times for specialty care.
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Future studies should consider the perspectives of the end-users (i.e., GPs and orthopedic
surgeons).

2.2.4.1 Electronic Order Entry Systems
Studies suggest that electronic order entry systems can effectively address the issue of
unnecessary ordering of MRI for the diagnosis of OA. These systems include features such
as structured templates and automated feedback to support the decision-making of ordering
providers. Khorasani et al.124 identified several potential benefits of electronic order entry
systems, including improved efficiency, selection of appropriate diagnostic imaging tests and
quality of care, as well as reduced healthcare costs. One study showed that an electronic
order entry system increased the appropriateness of imaging tests ordered by GPs by 25%.125
The findings of a systematic review further support the potential of electronic order entry
systems to significantly enhance the efficiency and effectiveness of imaging services.126
Consistent with other implementation research studies, this review reiterates the importance
of considering the circumstances of individual organizations that may facilitate or impede
their uptake and impact. Electronic order entry can be integrated into e-referral systems to
further improve efficiency and contain costs.

2.2.5 Proposed New e-Referral Pathway
The reviewed literature will inform the development and implementation of a NRP for
patients referred for surgical consideration of TKA. The fundamental goal of the NRP is to
serve as a guided e-referral system that facilitates shared decision-making regarding
appropriate and timely referral to orthopedic specialty care. Based on the theoretical
underpinnings of KT, the NRP will synthesize guideline recommendations, systematic
reviews and multidisciplinary expertise to provide relevant information to patients and
referring GPs within the local context.
Previous successful WTMS across Canada have demonstrated the importance of involving
key stakeholders (i.e., GPs, surgeons and patients) throughout the implementation process to
facilitate uptake and compliance.118 At the initial stages of designing the study, we engaged
various healthcare providers (i.e., GPs, orthopedic surgeons, sports medicine specialists, and
PTs) through brainstorming meetings to identify patient factors related to appropriateness for
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TKA. Afterward, a panel of orthopedic surgeons rated the most important outcomes of
surgical suitability using an informal modified Delphi consensus approach. These results
were then discussed at clinical research rounds until further consensus was reached.
Subsequently, we developed and validated a multivariable predictive model that is able to
identify the vast majority of surgical candidates (>90%), thereby reducing the proportion of
inappropriate referrals.27,28 To bypass the need for clinician involvement or interpretation, all
predictors included in the model are patient-reported. This model will lay the groundwork for
the NRP’s educational component, which will include information on conservative
management options, the roles of local healthcare professionals (e.g., PTs, occupational
therapists, sports medicine specialists, GPs who administer joint injections, etc.) and how to
access their services, appropriate diagnostic imaging tests, TKA and its associated outcomes,
as well as clear indication criteria for surgery. Furthermore, referring GPs would likely
benefit from having access to a physician directory, which provides a list of orthopedic
surgeons, their areas of specialization and projected wait times.77
Based on the findings from the reviewed literature, we designed a conceptual model of the
NRP that reflects a holistic approach and depicts its key features, relevant stakeholders, and
intended outcomes (Figure 2). Achieving the NRP’s success and sustainability will require an
ongoing, cyclical process resembling the knowledge-to-action cycle (depicted in Figure 1)82,
which involves adapting the knowledge to the local context, considering barriers to
knowledge uptake, tailoring the content and delivery strategy, monitoring use, and evaluating
outcomes through feedback from the end-users (i.e., patients and referring GPs). For optimal
uptake, it is important to provide end-users with an explanation of the NRP’s purpose and
potential benefits. From a patient perspective, the online system may be cost-saving by
avoiding the need for out-of-pocket expenses (e.g., for transportation, accommodation,
patient and caregiver time off from paid work, etc.). Furthermore, it would promote patient
autonomy by providing a private, self-paced learning environment that is accessible from
home and simulates real-life experiences.105 From a healthcare system perspective, the NRP
may expedite wait times for TKA by reducing the proportion of nonsurgical referrals and
redirecting them to alternative management options and providers, as well as decrease costs
associated with unnecessary imaging tests and surgical consultations. Furthermore, to
disseminate knowledge effectively, the NRP should adopt a user-friendly, tailored approach
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that delivers relevant information in a clear and comprehensible manner, while considering
individual differences (e.g., in age, gender, ethnicity, values, learning preferences, and visual
deficits that may occur with age).
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Figure 2: Key features, relevant stakeholders and intended outcomes of the NRP
Modern information technologies offer innovative approaches for knowledge mobilization.
Whiteboard videos may effectively convey complex health information by providing an
engaging and interactive learning experience.127,128 Furthermore, incorporating whiteboard
videos into the NRP would allow us to gain a better understanding of how patients and GPs
process and act on information by evaluating the impact of this new KT strategy on
knowledge acquisition and behaviour change. Dissemination strategies could take advantage
of existing social networking services. Finally, ongoing monitoring and evaluation of all
aspects of the NRP are essential for quality improvement. By addressing the issues of
unnecessary referrals and inefficiency of the current referral system, the NRP may ultimately
reduce wait times for TKA. Future studies will assess the cost-effectiveness of this referral
pathway and identify the factors that influence its uptake.
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2.3 Summary
Despite recent efforts to improve access to specialty care, wait times for TKA continue to
exceed the clinically acceptable benchmark. The rising demand for TKA, coupled with the
economic burden and detrimental health outcomes of excessive wait times, calls for the
development of new models of care. By providing the first point of contact, GPs play a
central role in the diagnosis and conservative management of knee OA, as well as in the
judicious selection of patients who may benefit from surgery. The issues of unwarranted
ordering of MRI scans, inadequate conservative management, and high rate of inappropriate
referrals indicate a need for innovative approaches to support consistent clinical decisionmaking in primary care.
We proposed a NRP as a strategy to reduce wait times for TKA by standardizing the referral
process and providing guidance for patients and referring physicians. The NRP will integrate
evidence-based recommendations with patient-reported predictors of surgical appropriateness
to provide education on appropriate imaging tests, conservative management, indications for
TKA and the risks and benefits of surgery, thereby promoting appropriate and timely referral.
Research on the topics of e-learning and e-referral is in its early stages, and thus the optimal
implementation methods remain unknown. We therefore designed a conceptual model of the
NRP, which was underpinned by KT theories and informed by the available evidence, that
involves key stakeholders and considers contextual factors that may influence uptake and
sustainability. Future studies will determine the cost-effectiveness of the NRP and identify
strategies to promote user engagement and improve the quality of care.
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Chapter 3

3

Objectives

We proposed a NRP as a strategy to reduce the proportion of inappropriate referrals and
decrease healthcare costs associated with unnecessary diagnostic imaging tests and surgical
consultations. The goal of the NRP is to support shared decision-making and promote
appropriate and timely referral to TKA, thereby improving access to specialty care for
patients who are sufficiently symptomatic, have exhausted conservative treatments, and are
willing to undergo surgery. A future, larger scale investigation will determine the costeffectiveness of the NRP compared to usual care.
The primary objective of this study was to measure healthcare resource use (i.e., conservative
treatments and diagnostic imaging tests), costs, and HRQoL in patients with knee OA at five
different stages along the continuum of usual care:
(1) Prior to referral,
(2) From referral to initial surgical consultation (WT1),
(3) From date of inclusion on surgical wait list to TKA (WT2) or, if not scheduled for
surgery, from initial consultation to one-year post-consultation
(4) From TKA until two years postoperative, and
(5) Approximately five years post-consultation.
The secondary objectives of this study were to determine the proportion and determinants of
inappropriate referrals, as well as to estimate WT1 and WT2.
The comparison of these outcomes before and after the implementation of the NRP will
enable us to evaluate its potential to promote the uptake of evidence-based recommendations
into primary care practice and ultimately reduce wait times for TKA.
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Chapter 4

4

Methods

This single-center prospective cohort study was conducted between December 2016 and
April 2018 in London, Ontario. Patients with knee OA were recruited at different stages
along the continuum of care and completed a series of questionnaires at the time of
recruitment (Appendix C). Participants were followed for a minimum of one-year postconsultation to a maximum of two years postoperative. Following initial consultation, the
attending surgeon completed a form outlining whether the patient was scheduled for surgery
(Appendix D). The institutional Health Sciences Research Ethics Board at the University of
Western Ontario granted approval for this study (Appendix A).

4.1 Eligibility Criteria
Patients over the age of 18 diagnosed with knee OA and referred to an orthopedic surgeon for
consideration of TKA were eligible for this study. Patients were excluded if they were unable
to complete the questionnaires in English or mentally unable to provide informed consent.
The study population consisted of four patient groups recruited at different stages of care: (1)
at the time of referral to an orthopedic surgeon (new referrals), (2) at their initial surgical
consultation (new consults), (3) at their pre-admission appointment prior to undergoing TKA
(pre-surgical patients), or (4) at approximately five years post-consultation (long-term
follow-up patients).

4.2 Participant Recruitment and Follow Up
Consenting patients were registered into a secure online data management system (EmPower
Health Research Inc.; www.empowerhealthresearch.ca) and completed a series of
questionnaires at the time of recruitment, either on paper or electronically using an iPad
(Model MD786CL/B, © Apple Inc.). Upon completion of paper questionnaires, the study
coordinator transcribed the data into the online system. Follow-up assessments were
conducted either electronically or over the phone. Patients who chose to participate online
were assigned a unique username and password to access the data management system.
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In addition to the automatic reminder emails sent by the system, the study coordinator sent
individualized emails to each participant prior to their follow-up assessment to provide
detailed instructions on how to sign in to the online system. To facilitate questionnaire
completion and maximize retention, the questionnaires were also attached to the email as a
fillable PDF document in the case of problems signing in. The remaining patients were
contacted by telephone or postal mail to obtain their responses to the questionnaires. Methods
of recruitment and follow-up assessments differed for each of the four patient groups and are
described below (Figure 2).

4.2.1 New Referrals
The study coordinator identified patients with knee OA who were referred to an orthopedic
surgeon and invited them to participate in the study via telephone shortly after their referral.
Patients who agreed to participate provided consent electronically or verbally over the phone.
New referrals completed the questionnaires at the time of referral and then on a weekly basis
until their surgical consultation (Figure 2).

4.2.2 New Consults
The study coordinator screened new consults for eligibility prior to their initial surgical
consultation. New consults were approached for recruitment in the joint replacement clinic
prior to their appointment. Following consultation, patients were either deemed appropriate
referrals and scheduled for TKA or inappropriate referrals and not booked for surgery.
Appropriate referrals completed follow-up assessments every three months until two years
postoperatively, whereas inappropriate referrals were followed for one year post-consultation
(Figure 2).

4.2.3 Pre-Surgical Patients
The study coordinator screened pre-surgical patients for eligibility prior to their preadmission appointment before TKA. Consenting patients completed the questionnaires
during their pre-admission appointment and then at 1.5 months, six months, and subsequently
every three months until two years postoperatively (Figure 2).
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4.2.4 Long-Term Follow-Up Patients
This group consisted of patients who were deemed inappropriate referrals in a previous study
that was conducted in 2013.129 The study coordinator contacted patients by telephone to
remind them about the study. Participants had been registered in the database in the previous
study and could choose to complete questionnaires online or over the phone. Completion of
the questionnaires concluded their participation in the study (Figure 2).

Figure 3: Outcome measures and follow-up frequencies for the four patient groups
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4.3 Outcome Measures
4.3.1 Patient Demographics
Upon recruitment, participants completed a demographics form and reported their age, sex,
height and weight (to calculate BMI), affected knee, unilateral/bilateral symptoms, previous
TJA, living arrangements, presence/absence of stairs at home, and global assessment of knee
pain. Global assessment of pain was measured by asking, “Considering all of the ways in
which knee pain and arthritis affect you, how are you doing today?” and recorded on a visual
analogue scale (VAS) ranging from 0 (very well) to 10 (very poorly). In addition, new
referrals and new consults reported their willingness to undergo surgery and Patient
Acceptable Symptom State 2 (PASS 2). Willingness to undergo surgery was measured using
a five-point Likert-type scale. We considered participants willing to undergo TKA if they
were “definitely willing” or “probably willing”. If participants were “unsure”, “probably
unwilling”, or “definitely unwilling”, they were deemed unwilling to undergo surgery and
asked to provide an explanation. PASS 2 is defined as the symptom threshold beyond which
patients no longer consider themselves well.130 Patients were asked to consider all the ways
in which knee pain and arthritis affect them, and whether they would be satisfied if they
remained in their current state for the next few months (yes/no).

4.3.2 Healthcare Resource Use
Upon recruitment, participants completed a questionnaire that captured the use of diagnostic
imaging tests and conservative treatments for knee OA, either prior to referral (for new
referrals and new consults) or following initial consultation (for pre-surgical and long-term
follow-up patients).
Patients reported their use of allied health services, including physiotherapy, chiropractic
therapy, and occupational therapy (yes; no, it was not recommended; or no, but it was
recommended). If participants responded “yes”, they were asked to specify the treatments
used (e.g., exercises, ice, heat, TENS, laser, etc.), the duration and frequency of therapy, their
level of compliance with the program (perfect compliance, 75%, 50%, 25%, or noncompliant), and whether they discontinued therapy sooner than recommended. If patients
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reported that they were 25% compliant or non-compliant, or if they stopped attending therapy
sooner than recommended, they were asked to select one or more reasons from a list of
social, environmental, and psychological factors. Patients who reported that they had not
pursued therapy despite it being recommended were asked to provide an explanation.
In addition, we captured previous use of IA injections (corticosteroid, HA, or other) and
services provided by massage therapists, osteopaths, acupuncturists, or pedorthists/orthotists.
Patients also reported whether they had tried any of the following conservative treatments:
exercise (aerobic, resistance, stretching, or other), weight loss, topical NSAIDs, knee bracing,
specialized footwear (e.g. insoles or orthotics), gait aids, and prescription or over-the-counter
medications.
Furthermore, we asked patients to report diagnostic imaging tests ordered by their referring
provider (x-ray, MRI, MRI arthrogram, CT, or ultrasound) and, if known, the results
(mild/moderate OA or severe OA). The purpose of this was twofold. Firstly, we wanted to
estimate the use of unnecessary imaging (e.g., MRI for the diagnosis of OA). Secondly, we
sought to determine the proportion of patients who were aware of their test results and could
therefore self-report this information in the NRP, thereby improving referral efficiency.
Finally, given that long-term follow-up patients were not scheduled for TKA at their initial
surgical consultation in 2013, we wanted to determine if they had undergone surgery
thereafter, if surgery was recommended but they opted out (if so, why), or if they were
scheduled for surgery at the time of data collection. Those who had undergone surgery were
asked to specify the surgical procedure(s) (i.e., meniscal repair, meniscal debridement,
meniscal excision, high tibial osteotomy, anterior cruciate ligament reconstruction, microfracturing of bone cartilage, implant insertion to repair a hole in bone cartilage, and/or other).

4.3.3 Health-Related Quality of Life
HRQoL was evaluated at the time of recruitment and at each follow-up using the WOMAC, a
disease-specific health status tool, and two measures of generic HRQoL: the 12-Item Short
Form Health Survey (SF-12; version 2) and the EuroQoL Five Dimensions Five-Level (EQ5D-5L) instrument. The WOMAC is a 24-item questionnaire that consists of three subscales:
pain (five items), stiffness (two items), and physical function (17 items). Questions are
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scored on a scale from 0 (none) to 4 (extreme) and then weighted and summed for each
subscale or totaled for an overall index. The WOMAC is extensively used to measure health
status among patients with hip and knee OA and has been widely reported to be valid,
reliable and responsive.131–133
The SF-12 (version 2) contains 12 questions that measure eight domains: general health,
bodily pain, physical functioning, role limitations due to physical health problems, vitality,
social functioning, mental health, and role limitations due to emotional problems. Questions
are weighted and summed to obtain two summary measures: a physical component score
(PCS) and a mental component score (MCS). The PCS and MCS range from 0 (worst health
state) to 100 (best health state). The SF-12 is a valid and reliable instrument for assessing
health status in the general population and has been shown to be the most valid and
responsive generic HRQoL tool for patients undergoing TJA.133,134 Marsh et al.135 reported
excellent inter-rater reliability between electronic and paper versions of the WOMAC and
SF-12 in patients following TJA.
Finally, the EQ-5D-5L consists of two components: a descriptive system and VAS
evaluation. The descriptive system contains five items or dimensions – mobility, self-care,
usual activities, pain/discomfort, and anxiety/depression – each scored on a five-point Likerttype scale. The scores can then be converted into a utility value from 0 (death) to 1 (perfect
health). This is particularly useful for economic evaluations that measure disease burden in
quality-adjusted life years, which are calculated by multiplying the utility value by the
amount of time spent in that health state. The second component measures patient-perceived
health state using a VAS ranging from 0 (the worst health you can imagine) to 100 (the best
health you can imagine). In patients referred for TJA, the EQ-5D-5L appears to have
moderate reliability and higher validity than the original three-level questionnaire (EQ-5D3L).136
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4.3.4 Costs
To better understand the current clinical pathway for knee OA, we established a standardized
costing framework and captured a wide range of costs along the continuum of care (from the
time of referral until two years post-operatively) from the healthcare payer (MOHLTC),
patient/private insurer, and societal perspectives. While the healthcare payer perspective
includes only the direct medical costs associated with OA (i.e., imaging tests, procedures,
provider time, hospitalizations and medications for patients over the age of 65 or with
disabilities), the societal perspective also accounts for out-of-pocket costs (e.g.,
transportation, parking, etc.) and productivity losses. Thus, the societal perspective captures
both the direct and indirect costs of knee OA incurred by patients, their caregivers, private
insurance companies, and the healthcare system.
Our costing approach consisted of two main steps: (1) quantifying the consumption of
healthcare resources on an individual patient level and (2) valuating each unit used. The
quantity of resources consumed is then multiplied by the unit cost to obtain the total cost per
patient.

4.3.4.1 Quantifying Healthcare Resource Use
Participants completed the 19-item cost questionnaires at the time of recruitment and at each
follow-up assessment. We measured the following direct costs associated with OA: GP and
specialist visits, inpatient hospital admissions, emergency room visits, allied health services,
diagnostic imaging tests, procedures, assistive devices, prescription and over-the-counter
medications, and any other relevant expenses. To capture indirect costs, we asked
participants to report their employment status and time lost from paid work, volunteering,
and homemaking activities (in days or hours). In addition, patients indicated whether they
received assistance from a spouse, relative or friend, the number of hours of assistance per
week (with healthcare, personal care, household chores, transportation, etc.), and whether
their caregiver was required to take time off from work. To facilitate questionnaire
completion, the online database saved participants’ medications and employment information
from the previous assessment, allowing for updates to be made in the case of a change.
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4.3.4.2 Valuating Resource Use
We used multiple data sources to obtain unit costs for each healthcare resource and estimate
the total mean cost per patient over the continuum of care. Costs of physician visits,
diagnostic tests, and medical procedures were obtained from the Ontario Health Insurance
Schedule of Benefits and Fees (effective March 1, 2016). The costs of allied health services
were calculated based on the hourly rates reported by the corresponding regulatory agencies.
The Patient Cost Estimator tool developed by the Canadian Institute for Health Information
provided hospital admission and surgery costs (derived using the case-mix group
methodology).137 This costing methodology aggregates inpatients with similar characteristics,
thereby providing precise estimates for most cases.138
We obtained the unit costs of medications from the Ontario Drug Benefit Formulary
(effective April 30, 2018)139 and added the applicable markup costs and dispensing fees. The
total cost per drug was calculated based on drug accessibility (prescription vs. over-thecounter) and individual patient’s coverage (Ontario Drug Benefit plan vs. private insurance
vs. out-of-pocket) (Appendix E).
Finally, we estimated productivity costs using the human capital approach. Time lost from
paid work was valued at the average hourly wage in Ontario reported by Statistics Canada.140
Informal caregiver assistance and time lost from volunteer and homemaking activities were
valued at the current minimum wage in Ontario (effective January 1, 2018).141 All costs were
adjusted to 2018 Canadian dollars.

4.3.5 Surgical Consultation Form
After seeing new consults, the attending surgeon completed a surgical consultation form
developed and refined by Churchill et al.129 and Malian et al.28 Surgeons classified patients as
appropriate or inappropriate candidates for TKA based on their radiographs and indicated
whether they had ordered x-rays for each consultation (provided that existing x-rays were
inadequate or unavailable).
Patients deemed appropriate surgical candidates were assigned to one of three priority
ratings:
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Priority rating 1: The consult should have occurred sooner (late referral).
Priority rating 2: The consult occurred at the appropriate time (timely referral).
Priority rating 3: The consult could have waited (early referral).
If timely referrals were not scheduled for surgery, surgeons specified a reason (e.g., patient
was unwilling to undergo surgery or had too many comorbidities). Surgeons also provided an
explanation for assigning priority rating 1 (e.g., arthritis has been advanced and symptomatic
for a long time). If surgeons triaged a patient as an early referral or considered that the patient
should not have been referred for TKA, they were asked to select one or more of the
following reasons: OA is not advanced, insufficient symptoms, age, occupation, patient
expectations, patient has not exhausted conservative treatments, patient may be more
appropriate for a sports orthopedic surgeon, or other.

4.4 Estimation of Sample Size
Based on current practice and feasibility considerations, we aimed to recruit a convenience
sample of 50 new referrals and a total of 300 new consults and pre-surgical patients
(n = 150/group) to capture a representative sample. Long-term follow-up patients (n = 166)
were recruited in a previous study.129

4.5 Data Analysis
We tabulated demographic characteristics for each group using descriptive statistics, with
means and standard deviations (SDs) for continuous variables and proportions for categorical
variables.
To address our primary objective, we calculated proportions for categorical outcomes
(healthcare resource use) and means ± SDs for continuous measures (costs, WOMAC, SF12, and EQ-5D-5L and VAS) at each follow-up. The median (IQR) and range (minimum to
maximum) were also added for non-normal distributions. We also plotted the trajectory of
continuous outcomes over time along with 95% CIs for each patient group. The EQ-5D-5L
scores were converted into utility values using the crosswalk link function developed by the
EQ Group to estimate the relationship between responses to the new EQ-5D-5L and existing
value sets (i.e., utility values) for the EQ-5D-3L.142 We used the United States EQ-5D-3L
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value set derived from a representative sample of the general population using the time-tradeoff valuation method.
To address the secondary objectives, we determined the proportion of appropriate vs.
inappropriate referrals based on the surgical consultation forms and reported the reasons why
patients were classified as inappropriate. We defined an inappropriate referral as any patient
who was not scheduled for surgery after the initial consultation (i.e., should not have been
referred to TKA, was an early referral, or was a timely referral but unwilling to undergo
surgery). We calculated the median ± interquartile range (IQR) for WT1 and WT2 based on
the dates of referral, initial surgical consultation, and TKA obtained through the hospital’s
electronic medical record. Given that some patients in the pre-surgical group were not
scheduled for surgery at their initial consultation (but rather at a follow-up consultation), we
also calculated the median wait time between the initial consultation and follow-up (i.e.,
decision to operate), and between the follow-up consultation and TKA.
Missing items were followed-up by phone, e-mail or postal mail, if possible. Questionnaires
were considered complete if they were fully complete or if the outcome measure could be
adequately calculated despite missing data. Participants who completed follow-up
assessments were included in the analysis.
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5

Results

Between December 2016 and April 2018, a total of 590 patients were screened for eligibility
(Figure 4). Of these, 369 were enrolled in the study and completed the baseline
questionnaires. Demographic characteristics were similar across the new referral, new
consult, and pre-surgical groups (Table 5). In addition, 25 patients recruited in a previous
study completed the questionnaires at their long-term follow-up. Similar to previous studies
conducted in this field10,12, a considerable proportion of participants were not available for
follow-up assessments. This was predominantly due to appointment
postponements/cancellations. In addition, a number of participants did not reach their next
assessment by the end of the follow-up period (Figure 4).
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Figure 4: Participant flow through the study
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Table 5: Demographic characteristics of study participants
New referrals
(𝒏 = 58)

New consults
(𝒏 = 192)

Pre-surgical
(𝒏 = 119)

Age (years)

68.3 ± 9.3

66.0 ± 9.5

66.8 ± 8.9

Female

31 (53.4)

116 (60.4)

68 (56.7)

BMI

31.4 ± 7.9

32.0 ± 8.3

34.9 ± 7.9

Dominant side – right

51 (87.9)

171 (89.1)

114 (95.0)

Affected knee – right

25 (43.1)

103 (53.6)

60 (50.0)

Contralateral symptoms

41 (70.7)

157 (81.8)

80 (66.7)

Previous joint replacement

6 (10.3)

19 (9.9)

40 (33.3)

Global rating of knee pain
(0–10)

6.6 ± 2.3

5.4 ± 2.4

5.3 ± 2.2

PASS 2 – yes

23 (39.7)

96 (50.0)

N/A

Alone

12 (20.7)

52 (27.1)

25 (20.8)

With spouse/partner

42 (72.4)

108 (56.3)

78 (65.0)

With family

3 (5.2)

32 (16.8)

17 (14.2)

Residential care facility

1 (1.7)

0

0

49 (84.5)

137 (71.6)

70 (58.3)

Retired

32 (55.2)

105 (55.3)

75 (63.0)

Full time

11 (19.0)

49 (25.8)

17 (14.2)

Part time

6 (10.3)

12 (6.3)

12 (10.0)

Self-employed

2 (3.4)

2 (1.1)

4 (3.4)

Volunteer

1 (1.7)

2 (1.1)

1 (0.8)

Long-term disability

0

8 (4.2)

4 (3.3)

Temporary sick leave

0

5 (2.6)

4 (3.3)

Unemployed

0

3 (1.6)

0

Other

0

4 (2.1)

2 (1.7)

5 (8.6)

29 (15.3)

12 (10.0)

$20,000–$40,000

13 (22.4)

49 (25.8)

24 (20.8)

$40,000–$60,000

7 (12.1)

29 (15.3)

24 (20.0)

Characteristic*

Living arrangements

Stairs at home – yes
Employment status†

Annual household income†
<$20,000

60
$60,000–$80,000

12 (20.7)

26 (13.7)

16 (13.3)

$80,000–$100,000

3 (5.2)

18 (9.5)

24 (20.0)

>$100,000

11 (19.0)

31 (16.2)

14 (11.7)

Undisclosed

2 (3.4)

8 (4.2)

5 (4.2)

50 (87.7)

149 (78.4)

90 (75.6)

Agreed to complete
questionnaires online‡

BMI, body mass index; TJA, total joint arthroplasty; TKA, total knee arthroplasty; PASS, patient
acceptable symptom state.
*Values are reported as means ± SD for continuous parameters and 𝑛 (%) for categorical parameters.
†
Data available for 53 new referrals, 184 new consults and 114 pre-surgical patients.
‡
Had access to a computer and an email address or could complete questionnaires online with the help
of a relative or friend.

5.1 Primary Objective
5.1.1 Healthcare Resource Use
We divided the results of the healthcare resource use questionnaire into two sections:
conservative treatments (Table 6) and diagnostic imaging tests (Table 7). Results are
presented by stage of care: (1) prior to referral, (2) from date of inclusion on the surgical wait
list to TKA (pre-surgery), and (3) from initial consultation during which patients were not
booked for TKA but were followed for approximately five years post-consultation (long
term).

5.1.1.1 Conservative Treatments
The frequency of conservative treatments tried at the three stages of care are listed in
Table 8. The most commonly used treatments at each stage of care were pharmacotherapy,
lifestyle/activity modification, and exercise. 73.8% of patients reported having used topical
NSAIDs prior to their referral, while 64% of long-term follow-up patients had tried
physiotherapy since their initial consultation. Prior to referral, 123 of 248 (49.6%) patients
had tried physiotherapy, of which 21 discontinued treatment sooner than recommended.
Unaffordability and pain were the two most commonly cited reasons for discontinuation. 11
patients chose not to pursue physiotherapy despite it being recommended for various reasons
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(e.g., skeptical about its benefits, could do exercises independently, insufficient symptoms,
too far away from home).
142 (57.3%) participants had received injections prior to referral, most often corticosteroid.
12 (4.8%) received a recommendation for injections but opted out. Reasons included patient
perceptions that injections are costly, ineffective in controlling symptoms in the long term, or
not needed at the time. The referring GP administered injections in 37.5% of the cases.
Analgesics and NSAIDs were the two most commonly tried drug classes prior to referral
(68.1% and 57.7%) and pre-surgery (58.8% and 66.4%).
Table 6: Patient-reported use of conservative treatments at different stages of care*

Conservative treatment

Prior to
referral†
(𝒏 = 248‡)

Pre-surgery§
(𝒏 = 119)

Long term‖
(𝒏 = 25)

Physiotherapy

123 (49.6)

40 (33.6)

16 (64.0)

No but recommended

11 (4.4)

1 (0.8)

0

Chiropractic therapy

17 (6.9)

6 (5.0)

2 (8.0)

No but recommended

1 (0.4)

0

0

Occupational therapy

7 (2.8)

4 (3.4)

1 (4.0)

No but recommended

0

0

0

33 (13.3)

9 (7.6)

4 (16.0)

8 (3.2)

1 (0.8)

1 (4.0)

18 (7.3)

7 (5.9)

1 (4.0)

57 (23.0)

14 (11.8)

2 (8.0)

Injections

142 (57.3)

33 (27.7)

4 (16.0)

Corticosteroid

122 (49.2)

29 (24.4)

0

37 (14.9)

1 (0.8)

1 (4.0)

10 (4.0)

2 (1.7)

1 (4.0)

2 (0.8)

0

1 (4.0)

12 (4.8)

1 (0.8)

1 (4.0)

Massage therapy
Osteopathy
Acupuncture
Pedorthist/orthotist
services

Hyaluronic acid
Unknown
Other
No but recommended
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Weight loss

53 (21.4)

34 (28.6)

8 (32.0)

20.0 ± 21.3

13.4 ± 13.1

31.2 ± 29.0

Exercise

176 (71.0)

92 (77.3)

17 (68.0)

Aerobic

128 (51.6)

75 (63.0)

12 (48.0)

Resistance

88 (35.5)

39 (32.8)

7 (28.0)

Stretching

116 (46.8)

67 (56.3)

9 (36.0)

4 (1.6)

0

2 (8.0)

201 (81.0)

93 (72.8)

11 (44.0)

92 (37.1)

52 (43.7)

7 (28.0)

Topical NSAID

183 (73.8)

70 (58.8)

8 (32.0)

Knee sleeve/brace

105 (42.3)

42 (35.3)

6 (24.0)

76 (30.6)

32 (26.9)

4 (16.0)

Medications

209 (84.3)

107 (89.9)

19 (76.0)

NSAIDs

143 (57.7)

79 (66.4)

7 (28.0)

Analgesics

169 (68.1)

70 (58.8)

6 (24.0)

Steroids

6 (2.4)

8 (6.7)

1 (4.0)

Anti-rheumatoid

5 (2.0)

3 (2.5)

0

22 (8.9)

24 (20.2)

0

Pounds lost, mean ± SD

Other
Activity modification
Gait aid

Specialized footwear

Other

*Values are reported as 𝑛 (%) unless otherwise indicated.
†

Data collected at the time of referral or initial consultation.
𝑛 = 190 new consults + 58 new referrals.
§
At pre-admission appointment prior to undergoing TKA.
‖
Approximately five years post-consultation.
‡

At the time of assessment, 48% (12 of 25) of long-term follow-up patients had undergone
surgery on their knee. Surgical procedures included unilateral TKA (n = 6), bilateral TKA (n
= 1), UKA (n = 1), arthroscopy (n = 2), high tibial osteotomy with microfacture (n = 1), and
meniscal repair with anterior cruciate ligament reconstruction (n = 1). Given that surgery has
a significant impact on patients’ quality of life and health-related costs, these outcomes are
reported separately for recipients of surgery at the long-term follow-up.
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5.1.1.2 Diagnostic Imaging
Prior to their referral, 238 of 248 (96%) patients had undergone x-rays and 52 (21%) had
undergone MRI examinations. In the long-term follow-up group, radiographs were obtained
for 68% of patients since their initial surgical consultation, while MRI scans were ordered for
20%. Most patients were aware of the results of their imaging tests. At initial surgical
consultation, the majority was able to report the results of their x-rays (64.7%) and MRI
scans (57.7%).
Table 7: Patient-reported use and results of diagnostic imaging tests at different stages
of care
Prior to referral
(𝒏 = 248†)

Pre-surgery§
(𝒏 = 119)

Long-term
follow-up‖ (𝒏 = 25)

X-ray
Mild/moderate OA
Severe OA
Unknown

238 (96.0)
12.2
52.7
35.3

38 (90.8)
5.3
65.8
28.9

17 (68.0)
2
7
8

MRI
Mild/moderate OA
Severe OA
Unknown

52 (21.0)
7.7
50.0
42.3

5 (4.2)
0
40.0
60.0

5 (20.0)
0
2
3

MRI arthrogram
Mild/moderate OA
Severe OA
Unknown

7 (2.8)
28.6
42.9
28.6

0

0

CT scan
Mild/moderate OA
Severe OA
Unknown

11 (4.4)
9.1
45.5
45.5

3 (6.4)
9
66.7
33.3

0

Ultrasound
Mild/moderate OA
Severe OA
Unknown

10 (4.0)
0
50.0
50.0

1 (2.1)
0
0
100

3 (12.0)
0
1
2

Imaging test and results*

*Values are reported as 𝑛 (%) for imaging tests and as % for test results.
†

Data collected at the time of referral or initial consultation.
𝑛 = 190 new consults + 58 new referrals.
§
Assessed at pre-admission appointment prior to undergoing TKA.
‖
Approximately five years post-consultation.
‡
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5.1.2 Costs
We calculated OA-related costs over the continuum of care from the healthcare payer,
patient/private insurer, and societal perspectives (Table 8). At each follow-up, a considerable
proportion of the total (societal) cost was incurred by the patient/private insurer (Figure 5).
Figures 6-8 illustrate the distribution of costs at initial surgical consultation, pre-surgery, and
long-term follow-up. At initial consultation, 27% of the total cost was attributed to informal
caregiver assistance with daily activities. Overall, productivity costs accounted for the
greatest proportion of total costs (79% at initial consultation, 82% at pre-surgery, 58% at
long-term follow-up for patients who had received surgical treatment, and 83% at long-term
follow-up for patients who had not undergone surgery). The greatest costs incurred by both
the healthcare payer and patient/private insurer were at 6 weeks post-surgery, reflecting the
costs of acute care (TKA and hospital stay) and post-operative rehabilitation. In the longterm follow-up group, patients who had received surgical treatment reported significantly
lower costs compared to those who did not undergo surgery.
Table 8: Costs over the continuum of care by payer perspective
Costs (by perspective)
Healthcare payer
(MOHLTC)

% of
total cost

Initial consultation
(𝑛 = 231†)
Mean ± SD
Median (IQR)
Range

116.48 ± 184.04
76.48 (118.78)
1,826.78

6.8%

1,598.39 ± 3,675.87
242.57 (1,113.86)
33,952.85

93.2%

1,714.87 ± 2,910.44
414.30 (1,128.96)
34,050.45

3 months postconsultation (𝑛 = 127)
Mean ± SD
Median (IQR)
Range

105.00 ± 198.91
42.60 (154.40)
1,749.42

3.8%

2,635.97 ± 6,677.55
279.51 (1,535.87)
52,495.00

96.2%

2,740.98 ± 6,684.52
417.80 (1,615.65)
52,562.40

6 months postconsultation (𝑛 = 93)
Mean ± SD
Median (IQR)
Range

103.86 ± 203.66
36.03 (154.40)
1,749.42

4.2%

2,318.86 ± 4,642.18
431.00 (1,891.03)
25,047.02

95.8%

2,422.73 ± 4,677.75
505.45 (2,130.84)
25,278.62

Stage of care

Patient/
private insurer

% of
total cost

Societal (total cost)
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9 months postconsultation (𝑛 = 52)
Mean ± SD
Median (IQR)
Range

65.41 ± 98.56
33.30 (83.39)
543.63

2.6%

2,589.05 ± 5,513.81
485.82 (2,024.21)
27,109.00

97.4%

2,615.69 ± 5,484.18
515.13 (2,045.97)
27,142.81

1 year postconsultation (𝑛 = 20)
Mean ± SD
Median (IQR)
Range

841.09 ± 2,226.33
64.58 (142.14)
7,397.00

15.0%

4,735.09 ± 10,454.90
499.39 (3,765.48)
44,551.65

85.0%

Pre-surgery
(𝑛 = 141‡)
Mean ± SD
Median (IQR)
Range

299.58 ± 82.35
262.45 (80.83)
381.35

12.6%

2,085.37 ± 5,033.54
122.54 (838.32)
28,464.61

87.4%

2,384.94 ± 5,055.13
461.39 (864.55)
28,708.60

6 weeks post-surgery
(𝑛 = 85)
Mean ± SD
Median (IQR)
Range

7,346.24 ± 288.71
7,269.91 (81.60)
1,970.83

50.1%

7,310.24 ± 8,879.38
4,936.84 (8,812.00)
65,772.14

49.9%

14,656.48 ± 8,838.40
12,453.66 (8,528.38)
65,814.74

6 months post-surgery
(𝑛 = 57)
Mean ± SD
Median (IQR)
Range

208.42 ± 957.91
64.80 (129.98)
7,284.65

15.5%

1,146.92 ± 3,254.51
59.31 (506.79)
19,093.26

84.5%

1,355.35 ± 3,598.62
219.42 (592.28)
19,093.26

9 months post-surgery
(𝑛 = 41)
Mean ± SD
Median (IQR)
Range

244.74 ± 1,154.54
24.05 (94.16)
7,434.99

15.4%

1,603.61 ± 4,691.87
195.31 (614.00)
23,266.93

84.6%

1,848.35 ± 4,819.13
241.70 (896.86)
23,606.02

1 year post-surgery
(𝑛 = 18)
Mean ± SD
Median (IQR)
Range

138.52 ± 328.40
45.87 (123.41)
1,422.10

5.1%

2,579.53 ± 4,446.37
143.31 (2,573.62)
13,763.00

94.9%

2,718.05 ± 4,646.69
244.79 (2,743.32)
15,185.10

15 months post-surgery
(𝑛 = 5)
Mean ± SD
Median (IQR)
Range

53.88 ± 73.44
9.05 (97.60)
162.73

60.3%

35.51 ± 76.34
0.00 (5.54)
172.00

39.7%

89.39 ± 123.63
9.05 (168.28)
269.60

5,576.17 ± 10,785.96
562.53 (5,153.33)
45,185.03
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Long term, surgery§
(𝑛 = 12)
Mean ± SD
Median (IQR)
Range

64.91 ± 97.92
0 (93.06)
293.85

39.8%

437.04 ± 1,224.50
7.05 (136.38)
4,110.00

60.2%

501.95 ± 1,244.17
43.30 (275.54)
4,210.28

Long term, no surgery§
(𝑛 = 14)
Mean ± SD
Median (IQR)
Range

816.58 ± 2,699.44
78.00 (176.76)
10,189.68

10.6%

1,228.30 ± 2,371.09
176.47 (1,657.89)
8,960.00

89.4%

2,044.88 ± 3,414.59
370.59 (1,938.54)
10,637.68

TKA, total knee arthroplasty.
*Costs are reported in 2018 CAD ($).
†𝑛 = 191 new consults + 40 new referrals.
‡𝑛 = 119 pre-surgical patients + 19 new consults + 3 new referrals who had undergone surgery at the end of the follow-up period.
§Costs reported separately for long-term follow-up patients who had undergone surgery on their knee since their initial consultation
and for those who did not.
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Figure 5: Knee OA-related costs over the continuum of care
(unadjusted means, 95% CIs)
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Figure 6: Distribution of direct and indirect costs of OA at initial surgical consultation

Figure 7: Distribution of direct and indirect costs of OA prior to surgery
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Figure 8: Distribution of direct and indirect costs of OA at long-term follow-up for
patients who had undergone surgical treatment vs. those who had not
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5.1.3 Quality of Life
EQ-5D (index and VAS), SF-12 (PCS and MCS), and WOMAC (pain, stiffness, function and
total) scores at referral, initial consultation, pre-surgery, and long-term follow-up are reported
in Table 9. Figures 9, 10, and 11 present the trajectory of HRQoL scores over the continuum
of care. Mean scores at referral, initial consultation, and pre-surgery were similar for all
HRQoL measures. Overall, patients reported an improvement in HRQoL post-operatively.
Similarly, patients in the long-term follow-up group who had received surgical treatment
reported better outcomes (higher EQ-5D and SF-12 scores and lower WOMAC scores)
compared to those who had not. The high variability in HRQoL scores at 12 months postconsultation and 15 months post-surgery may be explained by the small sample size at both
follow-ups (n = 25 and n = 5, respectively).
Table 9: QoL questionnaire scores at four stages along the continuum of care

Score*

Referral
(𝒏 = 58)

Consultation
(𝒏 = 231†)

Presurgery
(𝒏 = 151‡)

Long term,
had surgery§
(𝒏 = 12)

Long term,
no surgery§
(𝒏 = 14)

EQ-5D index (0–1)
Mean ± SD
Median (IQR)
Range

0.78 ± 0.15
0.82 (0.07)
0.75

0.78 ± 0.11
0.81 (0.06)
0.76

0.79 ± 0.10
0.82 (0.08)
0.68

0.88 ± 0.06
0.86 (0.00)
0.19

0.85 ± 0.08
0.85 (0.03)
0.29

EQ-5D VAS (0–100)
Mean ± SD
Median (IQR)
Range

65.9 ± 19.1
70.0 (23.0)
95.0

61.8 ± 18.9
62.0 (25.0)
90.0

64.2 ± 18.7
70.0 (29.75)
90.0

74.33 ± 22.10
80.5 (19.3)
74.0

79.2 ± 11.0
84.0 (16.0)
39.0

SF-12 PCS (0–100)
Mean ± SD
Median (IQR)
Range

30.5 ± 8.2
29.7 (10.2)
44.8

30.5 ± 8.0
30.1 (11.5)
45.8

31.2 ± 8.1
31.8 (11.2)
42.9

44.5 ± 10.4
46.4 (12.3)
37.3

41.7 ± 8.9
41.6 (10.3)
35.9

SF-12 MCS (0–100)
Mean ± SD
Median (IQR)
Range

52.8 ± 10.9
53.9 (16.5)
52.0

49.9 ± 12.2
51.2 (19.2)
60.3

52.4 ± 10.3
52.9 (16.6)
46.6

58.1 ± 6.9
59.8 (8.4)
22.9

51.6 ± 8.5
52.0 (11.6)
30.0

WOMAC pain (0–20)
Mean ± SD
Median (IQR)
Range

10.8 ± 3.6
11.0 (6.0)
16.0

10.3 ± 3.6
10.0 (5.0)
19.0

9.5 ± 3.8
10.0 (5.0)
18.0

3.8 ± 5.2
2.0 (5.3)
18.0

5.2 ± 4.8
4.0 (7.0)
14.0
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WOMAC stiffness (0–8)
Mean ± SD
Median (IQR)
Range

4.1 ± 1.9
4.0 (2.5)
8.0

4.5 ± 1.7
4.0 (2.0)
8.0

4.2 ± 1.7
4.0 (3.0)
8.0

2.0 ± 1.9
2.0 (2.5)
5.0

2.8 ± 2.4
2.0 (3.0)
8.0

WOMAC function (0–68)
Mean ± SD
Median (IQR)
Range

34.9 ± 12.5
34.0 (20.0)
52.0

34.9 ± 12.6
35.0 (17.0)
67.0

35.6 ± 11.8
37.0 (15.0)
67.1

12.0 ± 14.4
8.0 (17.0)
47.0

17.3 ± 15.4
14.0 (20.0)
45.0

Total WOMAC (0–96)
Mean ± SD
Median (IQR)
Range

49.8 ± 16.5
48.0 (25.5)
67.0

49.7 ± 16.8
50.0 (23.0)
92.0

49.1± 15.4
51.0 (21.0)
86.6

17.8 ± 20.6
11.5 (23.8)
70.0

25.2 ± 22.2
18.0 (31.0)
65.0

EQ-5D-5L, EuroQoL five dimensions five-level; VAS, visual analogue scale; SF-12, short form health survey
(12-item); MCS, mental component score; PCS, physical component score; WOMAC, Western Ontario and
McMaster Universities osteoarthritis index.
*Lower scores on the WOMAC and higher scores on the SF-12 and EQ-5D indicate better outcomes.
†𝑛 = 188 new consults + 43 new referrals.
‡𝑛 = 119 pre-surgical patients + 32 new consults who had undergone surgery at the time of analysis.
§

Costs are reported separately for patients in the long-term follow-up group who had undergone surgery on their
knee since their initial consultation.

Figure 9: Change in EQ-5D index and VAS scores over the continuum of care
(unadjusted means, 95% CIs)
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Figure 10: Change in SF-12 PCS and PCS over the continuum of care
(unadjusted means, 95% CIs)

Figure 11: Change in WOMAC scores over the continuum of care
(unadjusted means, 95% CIs)
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5.2 Secondary Objective
5.2.1 Proportion of Inappropriate Referrals
138 of 232 (59.5%) patients were scheduled for surgery following their initial consultation
(Table 10). Of the 137 patients deemed timely referrals, 10 were unwilling to undergo TKA.
The majority of referral requests (93.5%) were sent by a primary care provider.
In most cases (16 of 19), priority rating 1 was assigned because OA was advanced and
symptomatic for a long period of time. Priority rating 3 or no rating were most often assigned
to patients who had not yet exhausted conservative treatment options (54.5% and 35.2%,
respectively), followed by those with insufficient OA severity (40.1% and 35.2%,
respectively).
Table 10: Surgical appropriateness of new consults and new referrals* (𝒏 = 232)
Priority rating

𝑛 (%)

1 (late referral)

19 (8.2)
Scheduled for TKA (𝑛 = 119)

2 (timely referral)

Unwilling (𝑛 = 10)

137 (59.1)
Not scheduled (𝑛 = 18)

Comorbidity (𝑛 = 2)
Other (𝑛 = 6)

3 (early referral)

22 (9.5)

None†

54 (23.3)

TKA, total knee arthroplasty.
*𝑛 = 192 new consults + 40 new referrals who reached consult.
†Surgeon indicated that “patient should not have been referred to TKA at this time”.

Prior to surgical consultation, new referrals and new consults reported their willingness to
undergo surgery using a five-point Likert-type scale (Table 11). Patients who were “unsure”,
“probably unwilling” or “definitely unwilling” were asked to provide a reason. Overall, 46
patients (10.4% of new referrals and 20.3% of new consults) were unsure about or unwilling
to undergo TKA. Among these, 13 believed that there were other treatment options available,
10 cited a need for more information (about OA, the risks and benefits of surgery, and
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alternative treatments), nine reported insufficient symptoms for surgery, and nine were
willing to consider TKA as an option in the future (e.g., closer to retirement).
Table 11: Willingness to undergo surgery at referral and initial consultation
Willingness to undergo TKA

At referral
(𝒏 = 58)

At consultation
(𝒏 = 192)

Definitely willing

43 (74.1)

133 (69.3)

Probably willing

9 (15.5)

20 (10.5)

Unsure

3 (5.2)

21 (10.9)

Probably unwilling

3 (5.2)

15 (7.8)

Definitely unwilling

0

3 (1.6)

5.2.2 Wait Times
Overall, the mean wait time between referral and surgical consultation (WT1) was 3.6
months (range 0.1–18.4) and the mean wait time between date of inclusion on the surgical
wait list and TKA (WT2) was 9.6 months (range 1.4–22.2) (Table 12). At the end of the
follow-up period, three new referrals had undergone surgery. These patients had a
significantly shorter mean WT2 (3.6 months, range 2.5–4.3) compared to new consults (9.3
months, range 2.1–15.8) and pre-surgical patients (9.8 months, range 1.4–22.2).
Among patients recruited at their pre-admission appointment, those who were booked for
TKA at a follow-up visit (n = 62) waited a median of 1.7 years (range, 0.5 months–10.3
years) between initial consultation and booking for surgery.
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Table 12: Wait times (in months) from referral to initial consultation (WT1) and
from date of inclusion on surgical wait list to TKA (WT2)

Wait time (months)
New referrals
𝑛

WT1

Mean ± SD
Median (IQR)
Range (min, max)
𝑛

WT2

Mean ± SD
Median (IQR)
Range (min, max)

New consults

Pre-surgical

All patients

58

192

112*

362

3.8 ± 1.1
3.7 (1.2)
6.5 (1.8, 8.3)

3.1 ± 1.5
3.1 (1.8)
12.7 (0.1, 12.8)

4.2 ± 2.9
3.4 (2.5)
17.9 (0.5, 18.4)

3.6 ± 2.0
3.3 (1.8)
18.3 (0.1, 18.4)

3†

43‡

117§

163

3.6 ± 1.0
3.9 (0.9)
1.8 (2.5, 4.3)

9.3 ± 3.8
10.3 (5.2)
13.7 (2.1, 15.8)

9.8 ± 3.8
9.9 (5.1)
20.8 (1.4, 22.2)

9.6 ± 3.8
9.9 (5.4)
20.8 (1.4, 22.2)

*Date of referral was not available in the hospital’s electronic medical record for seven pre-surgical patients.
†Three
‡43

§

new referrals had undergone TKA at the time of analysis (WT2 = 2.5, 3.9 and 4.3 months).
new consults had undergone TKA at the time of analysis.

One patient cancelled TKA twice and had not undergone surgery at the end of the follow-up period (i.e.,
within 9.9 months of initial pre-admission appointment).
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Discussion

The purpose of this study was to evaluate healthcare resource use, costs and HRQoL in
patients with knee OA at different stages along the continuum of usual care. In addition, we
determined the rate and determinants of inappropriate referrals and estimated wait times from
referral to initial surgical consultation (WT1) and from consultation to TKA (WT2) at our
center. Our findings are consistent with previous studies that demonstrated that the current
primary care management of patients with knee OA is suboptimal. We found that
conservative treatments were underused prior to referral, while the ordering of diagnostic
imaging tests was not aligned with current CPGs. The perspective of the analysis had a
significant impact on the results. At each stage of care, a substantial proportion of total costs
were incurred by the patient/private insurer. While HRQoL remained relatively stable
throughout WT1 and WT2, participants reported an improvement in health status postoperatively. Our results emphasize the need for improved education and guidance for patients
and referring GPs to promote shared decision-making and appropriate and timely referral to
TKA.
Prior to being referred, a considerable number of patients had not tried many of the core
conservative treatments, including exercise (29%), injections (43%), physiotherapy (50%),
NSAIDs (42%), and analgesics (32%). CPGs for the management of knee OA consistently
recommend that all patients be offered a combination of pharmacological (NSAIDs,
acetaminophen, tramadol and IA corticosteroid injections) and nonpharmacological
interventions (education on self-management, exercise, weight loss, activity modification and
physiotherapy) before TKA is considered.25,35,43 Only those patients who continue to
experience significant pain and functional impairment despite conservative management
should be referred to an orthopedic surgeon for consideration of TKA.
Our results are in line with the findings from previous studies, which found that a large
subset of referrals are inappropriate and consists of patients who have not exhausted
nonsurgical treatment options.143,144 To capture the use of injections and services from
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alternative healthcare providers (physiotherapists, chiropractors, and occupational therapists),
we asked patients to distinguish between never having tried the treatment and never having
received a recommendation. For example, only 4% of patients indicated that they opted out
of receiving an IA joint injection despite it being recommended. This suggests that the 43%
of patients who reported never having tried injections had never received a recommendation
from their primary care provider.
Although MRI is typically not indicated for the diagnosis of OA68,71, 21% of participants
reported undergoing MRI examinations prior to their referral. Similarly, a US study of new
patients presenting with knee pain to an academic orthopedic sports medicine clinic (n = 599)
found that 22% of patients underwent MRI prior to referral.74 Furthermore, while older CPGs
recommend plain radiographs for the diagnosis of OA, the latest NICE guideline
recommends that it be made clinically without imaging tests if patients meet the following
three criteria: (1) are ≥45 years of age, (2) suffer from activity-related joint pain, and (3)
experience either no morning joint-related stiffness or morning stiffness that lasts <30
minutes.35 Nevertheless, pre-referral x-rays were obtained for 96% of participants. These
discrepancies between guideline recommendations and clinical practice indicate the need for
clear indications to streamline screening and avoid the ordering of costly and unnecessary
imaging tests.
A finding that is particularly relevant to the NRP is that most participants were aware of the
results of their diagnostic imaging tests. For example, 65% of newly referred patients knew
the results of their x-rays and 58% knew the results of their MRI. A feature of the NRP that
enables patients to self-report their test results would avoid an additional point-of-contact,
thereby improving the efficiency of the referral process.
To accurately assess the value of new clinical pathways for patients with knee OA, it is
important to capture costs and HRQoL across the entire continuum of care, from referral to
surgery and recovery. Healthcare costs are incurred by public payers (the MOHLTC), private
insurers, as well as individual patients and their caregivers. In the present study, we estimated
the costs and consequences of knee OA over time from the perspective of the MOHLTC,
patient/private insurer and society, and determined the proportion of costs borne by each
payer. Our results confirm the findings of other studies that have reported that the impact of
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OA falls beyond the boundaries of the healthcare system. Costs incurred by the
patient/private insurer accounted for the majority of the total (societal) mean cost at each
follow-up (>85% of the total cost during WT2).
Across the components of care, the greatest proportion of costs were attributed to indirect or
productivity costs. At initial surgical consultation, 38% of the mean total cost was attributed
to lost leisure time, 27% to informal caregiver assistance, and 14% to time off from paid
work. From the patient/private insurer perspective, costs increased during WT2, indicating
that the economic burden of OA can be reduced by addressing the issue of excessive wait
times for surgery. Hunter et al.20 argued that the overwhelming majority of OA-related costs
are indirect and that studies often adopt the healthcare payer perspective alone, thereby
underestimating the true burden of OA. A study commissioned by the Canadian Medical
Association compared four priority procedures and found that wait times for TJA amounted
to the highest societal costs.17 With an estimated 32% of patients unable to participate in their
usual activities, a large proportion of these costs were attributed to productivity losses.
Marshall et al.145 conducted a similar economic evaluation in Alberta to measure the costs of
TJA from one year pre-surgery to one year post-surgery. The authors found that the
perspective of the analysis (healthcare payer vs. patient) had a significant impact on the
results. 30% of the total cost was incurred by patients and attributed to time off work, travel
expenditures, medications, and alternative healthcare provider visits. The significant
variability in costs observed at each follow-up indicates that the majority of healthcare costs
are borne by a small subset of the patient population. As the economic burden of OA
continues to grow, it is important for WTMS to identify and target individuals who are at a
higher risk of incurring greater costs.
To our knowledge, this is the first study to capture the change in HRQoL between referral and
initial surgical consultation. Previous studies have looked at changes in HRQoL during
WT210, as well as investigated the impact of the pre-surgery waiting time on post-operative
health status.11,12 However, they did not take WT1 into account because of the methodological
challenges in recruiting patients at the time of referral.11 Contrary to the prospective cohort
study by Ackerman et al.10, which found that more than half of patients waiting for TKA
experienced a deterioration in HRQoL, our results suggest that patient health status remains
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relatively stable throughout WT1 and WT2. Other studies evaluated the effect of waiting for
TKA on post-operative outcomes and found that longer pre-surgery wait times (>6 and >9
months) were associated with poorer SF-36 and WOMAC scores at six months post-surgery11,
and poorer SF-12 and Knee Society function scores at one year post-surgery.12 This, coupled
with the post-operative improvement in HRQoL observed in our study, suggests that shorter
wait times would enable patients to achieve improved health status and wellbeing sooner.
The mean wait times were 3.6 months from referral to surgical consultation and 9.6 months
from consultation to TKA, exceeding the national benchmarks (3 months and 6 months).4 We
found that 41% of newly referred patients were not scheduled for TKA following their initial
surgical consultation. This is similar to the proportion of inappropriate referrals previously
reported at our center (>40%)28,129 and in another study conducted in Ontario (47%).143
Furthermore, nearly 20% of patients indicated that they were unwilling to undergo TKA,
often citing inadequate conservative treatment, insufficient symptoms, and a lack of
information as the primary reasons. Using the same five-point Likert-type scale, a
population-based cohort study found that 66% (250 of 379) of individuals with disabling hip
and knee OA were unwilling to consider TJA as a treatment option.66 Unwillingness was
strongly associated with misperceptions about the indications for surgery and post-operative
outcomes. These findings underscore the importance of patient and GP education and other
strategies emphasizing appropriate and timely referral for improving the quality of both
primary and specialty care.
This study captured a wide range of costs over a relevant time horizon and from multiple
perspectives, revealing the significant patient burden incurred through out-of-pocket costs and
productivity losses throughout the continuum of care. We also administered a unique and
comprehensive questionnaire, developed and refined in previous studies conducted at our
center27,28, to capture the use of conservative treatments (allied health services, injections, and
self-management strategies) and diagnostic imaging tests at different stages of care. In
addition, we integrated additional follow-up questions to elucidate the barriers to treatment
use and inform future efforts to optimize the conservative management of knee OA. Given the
growing socioeconomic burden of OA, new strategies are needed to allocate healthcare
resources more efficiently and tackle excessive wait times for TKA.
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6.1 Limitations
This study has several limitations. First, the high attrition rate and small sample sizes at
follow-up assessments decreased the precision of the cost and HRQoL estimates, as indicated
by the large CIs (especially at 12 months post-consult and 15 months post-surgery) and quite
possibly the validity of the estimates, although attrition was largely attributed to appointment
postponements/cancellations or participants not reaching their next assessment by the end of
the follow-up period. This suggests a random, rather than a systematic, component to
missingness, thereby reducing the risk of bias.
Second, the post-operative follow-up period was limited to only 15 months. The latest edition
of the national guidelines for economic evaluation recommends that the time horizon be long
enough to capture all relevant costs and outcomes.146 Although the most important changes in
health status have been reported to occur during the 12-month post-operative period147, the
selected time horizon was not sufficiently long to account for revision TKA. Given that
revision TKA has a significant impact on costs and patient-reported outcomes, it would be
appropriate to measure outcomes beyond the short–medium term.
Third, the healthcare resource use and cost estimates used in this single-center cohort study
are specific to the local context. For instance, inpatient care at teaching hospitals is generally
costlier due to the additional resources required for training and research.148 Consequently,
the generalizability of our findings to other settings is unclear. However, the conclusions
about the importance of capturing costs from multiple perspectives along the continuum of
care are relevant outside this context. It is worth noting that we valued leisure time and
unpaid caregiver assistance at the current minimum wage in Ontario ($14.00/hour, effective
January 1, 2018). However, there is considerable variability in the costing approaches used to
estimate indirect costs incurred by patients and caregivers, making comparisons challenging.
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Conclusion

We found that the use of conservative treatments and diagnostic imaging tests was not
aligned with evidence-based guidelines, suggesting that the current primary care
management of knee OA is suboptimal. At each stage along the continuum of care, a
considerable proportion of total costs were borne by the patient or private insurer, rather than
the public healthcare payer (MOHLTC). While patient-reported health status remained
relatively stable from the time of referral until surgery, we observed an improvement in
HRQoL post-operatively. Our results emphasize the need for increased guidance and
decision support at the primary care level to address the current evidence-to-practice gap and
promote appropriate and timely referral to TKA.

7.1 Future Directions
The escalating societal costs of knee OA underscore the need for innovative and sustainable
strategies to reduce wait times without compromising the quality of patient care. This study
evaluated healthcare resource use, costs and HRQoL over the continuum of usual care, prior
to the implementation of the NRP. A subsequent study will determine the cost-effectiveness
of the proposed NRP and its impact on wait times for initial surgical consultation and,
ultimately, TKA.
Given the small sample size, the results of this study are preliminary and require further
validation. However, they offer valuable insight into the shortcomings of current clinical
practice and emphasize the importance of developing primary care interventions that target
both patients and referring GPs. Thus, the present findings provide guidance on the design
and implementation of the NRP and the optimization of resource allocation for patients with
knee OA. The inclusion of additional orthopedic centers with varying patient volumes would
improve the generalizability of our findings. Given the variety of WTMS that have been
proposed and implemented across Canada, the evaluation of alternative clinical pathways is a
much-needed focus for future research efforts to determine the most cost-effective model of
care.
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Appendix B: Letter of Information and Consent

Letter of Information
Study Title: A study to investigate the cost-effectiveness of a new referral pathway for total knee replacement
(TKR)
Principal Investigators:
Robert Giffin, MD FRCSC
Fowler Kennedy Sports Medicine Clinic
3M Center
London, ON
Steven MacDonald, MD FRCSC
London Health Sciences Centre
University Hospital
London, ON
INTRODUCTION
You are being invited to participate in a research study because you are currently at your first consultation with
the orthopedic surgeon at LHSC-University Hospital for your knee condition. To decide whether or not you
want to be part of this research study, you should understand what is involved and the potential risks and
benefits. This form gives detailed information about the research study, which will be discussed with you. Once
you understand the study, you will be asked to indicate this on the consent form and begin the survey, if you
wish to participate. Please take your time to make your decision. Feel free to discuss it with your friends and
family, or your family physician.
PURPOSE
The purpose of this study is to compare costs and changes in health-related quality of life (HRQoL) among 2
groups of patients; 1) usual care, and 2) after the implementation of new-referral pathway. We have previously
demonstrated that nearly 50% of patients referred to joint replacement specialists are not currently operative at
the time of initial referral. The primary reasons patients were not booked for surgery after their initial consult
include: patient unwilling to undergo surgery, patient lack of advanced disease progression and symptoms,
patient had not yet tried conservative treatment (e.g. physiotherapy).
Given long wait times to access TKR, and the associated costs patients and the healthcare system incur related
to these appointments, it would be advantageous to reduce the proportion of patients referred to TKR who are
not suitable candidates at the time of referral. An electronic referral system that screens incoming knee referrals
and provides education for patients and referring providers may help to reduce this proportion and improve
access to care for suitable surgical candidates. This study will measure wait times, costs, and health-related
quality of life outcomes throughout the usual referral and wait pathway (usual care), and then again after we
implement the new e-referral pathway (NRP) as part of a practice change at LHSC.
The new referral pathway (NRP) is a web-based guided referral system that aims to screen referrals to TKR,
providing patients and physicians with education to improve knee OA management, and to reduce the
proportion of non-operative referrals to TKR. Decreasing the proportion of non-operative referrals may help
reduce the total wait for surgery and associated costs.
DESCRIPTION OF STUDY
There will be approximately 600 patients enrolled in this study. The total time commitment for this study is
variable based on individual wait times, and whether or not you proceed with surgery. Your participation will
take approximately 20 minutes for each follow up. To participate in this study, you will need to provide an
email address for the purpose of creating an account to access the study materials. If you do not have an email
address, we encourage you to provide a family member’s email address who is willing to help you access the
study materials. Also, if your email address contains your name or any identifiers, you may wish to create a new
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email address for study purposes, although this is not required. You will receive an email reminder when you
are required to complete forms, which must be completed online.
You are in the usual care group because we have not yet made changes to the way the referral system functions.
If you choose to participate in this study, we will ask you to complete a series of online forms that query your
basic demographics, general health, and your knee condition. We will also ask you to report your health related
expenses online via standard forms. Completions of these forms are not part of usual care, and only pertain to
your participation in this study. Whether or not you are booked for a total knee replacement at your first
consultation, we will ask you to continue reporting your health-related expenses and HRQoL every 3 months up
until 1 year after your first consultation. The length of the visit is not affected by your decision to participate in
this study. This will conclude your participation.
RISKS
There are no known risks to your participation in this study. All patient and caregiver data will be secured, but
there is a remote chance of a privacy breach, in which case patients will be immediately informed.
BENEFITS
There are no known benefits to you for participating in this study; however, this study will provide an in-depth
understanding of the perspectives and experiences of both patients and health care professionals, providing
valuable data to inform care decisions and improvements.
CONFIDENTIALITY
All information will be kept confidential to the best of our ability. Any personal health information collected or
other information related to you will be coded by a unique number to ensure that persons outside of the study
will not be able to identify you. In any publication, presentation or report, your name will not be used and any
information that discloses your identity will not be released or published unless required by law. Despite these
protections being in place, there is always a risk of unintentional release of information. The study personnel
will protect your records and keep all the information in your study file confidential to the greatest extent
possible. The chance that this information will be accidentally released is small.
The data that is collected from you is managed by a company called EmPower Health Research. Any
information provided by you is protected by a username and password. It travels in a scrambled format to a
server (storage computer) that is located in Montreal, Canada. Your email address and your date of birth are part
of this database. The database will send automatic reminder emails to you if you are required to login and
answer questions. Instructions for logging into the database will be provided by the research assistant. The
company that houses the database is a professional company with extremely high standards of physical and
virtual security. We want to let you know however, that even with this high level of security, there is always a
remote chance that your information could be accessed or “hacked” by someone who is not supposed to have
your information. If we became aware that this had happened, we would inform you immediately. We wish to
make you aware that Dr. Bryant, who is one of this study's investigators, is the Director of EmPower Health
Research. However, Dr. Bryant is not paid a salary by EmPower.
Study data will be kept for fifteen years. Representatives of the University of Western Ontario Health Sciences
Research Ethics Board may require access to your study-related records or follow-up with you to monitor the
conduct of this research. Representatives of Lawson Quality Assurance (QA) Education Program may look at
study data for QA purposes.
VOLUNTARY PARTICIPATION
Participation in this study is completely voluntary. You may refuse to participate, refuse to answer any
questions or withdraw from the study at any time with no effect on your future care. Should you choose to
withdraw from this study, we will keep all data obtained up to the point that you chose to withdraw.
Participation in this study does not prevent you from participating in any other research studies at the present
time or future. If you are participating in another research study, we ask that you please inform of us of your
participation. You do not waive any legal rights by signing the consent form. If you would like to withdraw
from this study, you will need to provide written or verbal confirmation to the study coordinator: Laura
Churchill or Kate Lebedeva.
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COST/COMPENSATION
There are no additional costs to you for participating in this study. There is no compensation for participating in
this study.
CONTACT FOR QUESTIONS
If you have any questions about your rights as a research participant or the conduct of this study, you may
contact Dr. David Hill, Scientific Director, Lawson Health Research Institute 519-667-6649. For more
information concerning this study and research-related risks or injuries, you may contact the Principal
Investigator, Dr. Robert Giffin, at 519-661-3454 ext. 83454 or the graduate student Laura Churchill, at 519-4945471 or lchurch2@uwo.ca, or Kate Lebedeva, at 416-821-5567 or ylebedev@uwo.ca.
If you would like to receive a copy of the study results once they have been published, please indicate this on
the letter of consent. Please be aware that the study results may not be available for up to 5 years. It is your
responsibility to update your contact information with the researcher should it change. This letter is yours to
keep for future reference. Thank you for considering participation in this study. We appreciate your time and
interest.
Sincerely,
Dr. Robert Giffin, MD FCRSC, EMBA
Dr. Steven MacDonald, MD, FCRSC
Dr. Dianne Bryant, PhD
Laura Churchill, MPT/PhD (candidate)
Kate Lebedeva, MSc (candidate)

Letter of Consent

Study Title: A study to investigate the cost-effectiveness of a new referral pathway for total knee replacement
(TKR)

I have read the Letter of Information, have had the nature of the study explained to me and I agree to
participate. All questions have been answered to my satisfaction. I will maintain a copy of the LOI on the
online database.
Completion of the baseline survey indicates your consent to participate.
☐ Yes I would like to participate and begin the online survey. Upon registering in the database, the system will
send you an email with a link where you can go to set up your password.
☐ Yes, I would like to receive a copy of the study results once the study has been published.
☐ No, I am not interested in participating in this study.

98

Appendix B: Patient Questionnaires
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Note that the phrasing of the healthcare resource questionnaire (pages 2–7 below) differed
depending on the stage of care. New referrals and new consults were asked to report the use
of conservative treatments and diagnostic imaging tests prior to their referral, whereas presurgical and long-term follow-up patients were asked to recall resource use since their initial
surgical consultation.
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Appendix C: Surgical Consultation Form
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Appendix D: Cost Estimate Calculations for Prescription and Over-the-Counter Drugs
Prescription

OTC

Coverage

Ontario Drug Benefit Plan

Private insurance/
out-of-pocket

Out-of-pocket

Cost

Amount MOHLTC pays × 1.08 + 8.83

Drug benefit price × 1.1 + 10.69

Drug benefit price × 1.1

Perspective

Healthcare payer

Societal
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